http://pharmadispatch.com/news/no-shortage-of-pbs-expertise-for-new-minister 2015-01-12T17:00:01+11:00 http://pharmadispatch.com/news/new-listings-dominate-march-agenda 2015-01-12T17:00:01+11:00 http://pharmadispatch.com/news/cabinet-documents-reveal-not-much-has-changed 2015-01-12T17:00:01+11:00 http://pharmadispatch.com/news/chf-urges-caution-on-regulation 2015-01-12T17:00:01+11:00 http://pharmadispatch.com/news/co-pay-approaching-40 2015-01-12T17:00:01+11:00 http://pharmadispatch.com/news/cabinet-considered-impact-of-tpp-ip-provisions 2015-01-13T17:00:01+11:00 http://pharmadispatch.com/news/pbs-doesnt-even-rate-a-mention-in-new-budget-report 2015-01-13T17:00:01+11:00 http://pharmadispatch.com/news/pbs-schedule-changes 2015-01-14T17:00:01+11:00 http://pharmadispatch.com/news/chf-ceo-exits 2015-01-13T17:00:01+11:00 http://pharmadispatch.com/news/more-submissions-to-tga-review 2015-01-13T17:00:01+11:00 http://pharmadispatch.com/news/uk-defunds-some-cancer-drugs 2015-01-14T17:00:01+11:00 http://pharmadispatch.com/news/bms-immunotherapy-shines-in-another-trial 2015-01-14T17:00:01+11:00 http://pharmadispatch.com/news/shire-resets-after-abbvie 2015-01-14T17:00:01+11:00 http://pharmadispatch.com/news/another-state-backs-pharmacy-vaccination 2015-01-14T17:00:01+11:00 http://pharmadispatch.com/news/pbac-chair-calls-for-global-approach-to-drug-pricing 2015-01-15T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-developing-pcsk9-pill-and-vaccine 2015-01-15T17:00:01+11:00 http://pharmadispatch.com/news/embarrassment-for-the-fda 2015-01-15T17:00:01+11:00 http://pharmadispatch.com/news/jj-wants-major-reforms 2015-01-15T17:00:01+11:00 http://pharmadispatch.com/news/cancer-treatment-at-a-special-point-in-history 2015-01-16T17:00:01+11:00 http://pharmadispatch.com/news/chf-calls-for-national-summit 2015-01-16T17:00:01+11:00 http://pharmadispatch.com/news/sometimes-equity-needs-to-trump-cost 2015-01-16T17:00:01+11:00 http://pharmadispatch.com/news/confusion-over-biosimilars 2015-01-19T17:00:01+11:00 http://pharmadispatch.com/news/acoss-makes-bizarre-pbs-claim-in-budget-submission 2015-01-19T17:00:01+11:00 http://pharmadispatch.com/news/pointless-debate-on-advertising-ignores-reality 2015-01-19T17:00:01+11:00 http://pharmadispatch.com/news/health-no-longer-part-of-the-inner-sanctum 2015-01-19T17:00:01+11:00 http://pharmadispatch.com/news/companies-front-hep-c-inquiry 2015-01-19T17:00:01+11:00 http://pharmadispatch.com/news/guild-wants-in-on-medicare-consultation 2015-01-20T17:00:01+11:00 http://pharmadispatch.com/news/chf-dont-forget-consumers 2015-01-20T17:00:01+11:00 http://pharmadispatch.com/news/uk-cancer-outcomes-still-lagging-comparable-countries 2015-01-20T17:00:01+11:00 http://pharmadispatch.com/news/gilead-to-appeal-patent-rejection 2015-01-20T17:00:01+11:00 http://pharmadispatch.com/news/its-all-about-certainty 2015-01-21T17:00:01+11:00 http://pharmadispatch.com/news/self-care-boosting-blackmores 2015-01-21T17:00:01+11:00 http://pharmadispatch.com/news/industry-unites-on-labelling-change-timeline 2015-01-21T17:00:01+11:00 http://pharmadispatch.com/news/europe-to-share-generic-drug-assessments-with-tga 2015-01-21T17:20:01+11:00 http://pharmadispatch.com/news/no-time-to-wait-on-new-therapies-groups-tell-inquiry 2015-01-22T17:00:01+11:00 http://pharmadispatch.com/news/intervention-required 2015-01-23T17:00:01+11:00 http://pharmadispatch.com/news/new-leadership-for-genzyme-australia 2015-01-22T17:00:01+11:00 http://pharmadispatch.com/news/psa-updates-guidelines-as-states-move-on-vaccination 2015-01-22T17:00:01+11:00 http://pharmadispatch.com/news/jj-raises-2015-outlook 2015-01-22T17:00:01+11:00 http://pharmadispatch.com/news/is-the-pbac-taking-on-too-much 2015-01-22T17:00:01+11:00 http://pharmadispatch.com/news/tga-scraps-naming-convention 2015-01-22T17:00:01+11:00 http://pharmadispatch.com/news/perth-boy-first-to-receive-new-insulin-device 2015-01-22T17:00:01+11:00 http://pharmadispatch.com/news/hepatitis-australia-collective-anguish-over-access-wait 2015-01-23T17:00:01+11:00 http://pharmadispatch.com/news/acoss-pbs-budget-claims-in-tatters 2015-01-23T17:00:01+11:00 http://pharmadispatch.com/news/cdf-chair-regrets-undermining-nice 2015-01-23T17:00:01+11:00 http://pharmadispatch.com/news/can-we-finally-end-this-phoney-debate 2015-01-27T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-move-on-teva 2015-01-27T17:00:01+11:00 http://pharmadispatch.com/news/pbs-data-hard-to-read-but 2015-01-27T17:00:01+11:00 http://pharmadispatch.com/news/recognition-for-clinicians-and-medical-researchers 2015-01-27T17:00:01+11:00 http://pharmadispatch.com/news/pbac-recommends-roches-kadcyla 2015-01-27T17:00:01+11:00 http://pharmadispatch.com/news/queensland-lnp-backs-pharmacy 2015-01-27T17:00:01+11:00 http://pharmadispatch.com/news/consumers-back-pharmacy-in-primary-care 2015-01-27T17:00:01+11:00 http://pharmadispatch.com/news/otsuka-launches-australian-operation 2015-01-28T17:00:01+11:00 http://pharmadispatch.com/news/private-equity-backing-for-mdbriefcase 2015-01-28T17:00:01+11:00 http://pharmadispatch.com/news/medtronic-completes-covidien-acquisition 2015-01-28T17:00:01+11:00 http://pharmadispatch.com/news/transformational-year-for-novartis 2015-01-28T17:00:01+11:00 http://pharmadispatch.com/news/mid-range-per-capita 2015-01-28T17:00:01+11:00 http://pharmadispatch.com/news/us-dollar-hits-pfizer-sales 2015-01-28T17:00:01+11:00 http://pharmadispatch.com/news/international-comparisons-not-always-what-they-seem 2015-01-29T17:00:01+11:00 http://pharmadispatch.com/news/actavis-transformation-underway 2015-01-29T17:00:01+11:00 http://pharmadispatch.com/news/amgen-comfortably-beats-expectations 2015-01-29T17:00:01+11:00 http://pharmadispatch.com/news/bms-looks-to-new-products 2015-01-29T17:00:01+11:00 http://pharmadispatch.com/news/gates-warns-against-vaccine-price-cut 2015-01-30T17:00:01+11:00 http://pharmadispatch.com/news/ranbaxy-highlights-strong-growth-of-australia-business 2015-01-30T17:00:01+11:00 http://pharmadispatch.com/news/api-not-expecting-more-reform 2015-01-30T17:00:01+11:00 http://pharmadispatch.com/news/currency-impacts-roche 2015-01-30T17:04:01+11:00 http://pharmadispatch.com/news/well-walk-says-ma 2015-02-02T17:00:01+11:00 http://pharmadispatch.com/news/hsd-growing-fast-but-pbs-still-falling 2015-02-02T17:00:01+11:00 http://pharmadispatch.com/news/what-an-absolute-nonsense 2015-02-02T17:00:01+11:00 http://pharmadispatch.com/news/consumers-win-as-pfizer-fights-on-price 2015-02-02T17:00:01+11:00 http://pharmadispatch.com/news/more-support-for-pharmacy-vaccination 2015-02-02T17:00:01+11:00 http://pharmadispatch.com/news/results-lilly-biogen-novo-nordisk-celgene-abbott 2015-02-02T06:56:01+11:00 http://pharmadispatch.com/news/sector-helps-fund-political-process 2015-02-03T17:00:01+11:00 http://pharmadispatch.com/news/chemmart-launches-ovarian-cancer-campaign 2015-02-03T17:00:01+11:00 http://pharmadispatch.com/news/early-staff-changes-for-sussan-ley 2015-02-03T17:00:01+11:00 http://pharmadispatch.com/news/australian-prescriber-backs-common-sense-on-conflicts 2015-02-03T17:00:01+11:00 http://pharmadispatch.com/news/abbvie-with-high-hopes-for-hep-c-therapy 2015-02-03T17:00:01+11:00 http://pharmadispatch.com/news/australias-greatest-cancer-challenge 2015-02-04T17:00:01+11:00 http://pharmadispatch.com/news/novartis-welcomes-new-xolair-approval 2015-02-04T17:00:01+11:00 http://pharmadispatch.com/news/are-hopes-for-a-second-mou-fading-1 2015-02-04T17:22:01+11:00 http://pharmadispatch.com/news/political-drama-comes-at-the-worst-time 2015-02-05T17:00:01+11:00 http://pharmadispatch.com/news/amgen-gets-busy-on-biosimilars 2015-02-05T17:00:01+11:00 http://pharmadispatch.com/news/gilead-supercharged 2015-02-05T17:00:01+11:00 http://pharmadispatch.com/news/pbs-falling-behind-says-ma-chief 2015-02-05T17:00:01+11:00 http://pharmadispatch.com/news/ma-cautions-on-igr 2015-02-05T17:00:01+11:00 http://pharmadispatch.com/news/accc-backdown-on-code 2015-02-09T20:00:01+11:00 http://pharmadispatch.com/news/results-merck-co-gsk-and-astrazeneca 2015-02-06T17:19:01+11:00 http://pharmadispatch.com/news/tga-approves-new-hiv-triple-therapy 2015-02-06T17:02:01+11:00 http://pharmadispatch.com/news/sue-hill-resigns-as-pbac-chair 2015-02-05T23:47:01+11:00 http://pharmadispatch.com/news/a-legacy-worth-debating 2015-02-06T17:00:01+11:00 http://pharmadispatch.com/news/change-at-the-top-for-bayer 2015-02-06T17:24:01+11:00 http://pharmadispatch.com/news/pfizer-to-buy-hospira 2015-02-06T17:35:01+11:00 http://pharmadispatch.com/news/ley-acts-on-myozyme 2015-02-09T17:00:01+11:00 http://pharmadispatch.com/news/federal-court-backs-bayer-on-eylea 2015-02-09T17:00:01+11:00 http://pharmadispatch.com/news/mp-you-reap-what-you-sow 2015-02-09T17:00:01+11:00 http://pharmadispatch.com/news/janssen-delisting-diabetes-drug 2015-02-09T17:00:01+11:00 http://pharmadispatch.com/news/ley-to-oppose-spill-motion-non-committal-on-leadership 2015-02-09T17:00:01+11:00 http://pharmadispatch.com/news/opportunity-in-instability 2015-02-10T17:00:01+11:00 http://pharmadispatch.com/news/who-next-for-pfizer 2015-02-10T17:00:01+11:00 http://pharmadispatch.com/news/no-backdown-on-pbs-co-pays 2015-02-10T17:00:01+11:00 http://pharmadispatch.com/news/tim-james 2015-02-10T17:00:01+11:00 http://pharmadispatch.com/news/time-for-a-review 2015-02-10T17:02:01+11:00 http://pharmadispatch.com/news/new-market-access-head-for-pfizer 2015-02-11T17:00:01+11:00 http://pharmadispatch.com/news/cancer-inquiry-extended 2015-02-11T17:00:01+11:00 http://pharmadispatch.com/news/australia-finally-implements-trips 2015-02-12T05:00:01+11:00 http://pharmadispatch.com/news/pharma-the-losers-from-rd-tax-changes 2015-02-11T17:01:01+11:00 http://pharmadispatch.com/news/role-for-pharmacy-in-boosting-bowel-cancer-screening 2015-02-12T17:00:01+11:00 http://pharmadispatch.com/news/budget-submissions-psa-and-asmi 2015-02-12T17:00:01+11:00 http://pharmadispatch.com/news/quilty-negotiation-is-urgent-and-time-critical 2015-02-13T05:00:01+11:00 http://pharmadispatch.com/news/ausbiotech-government-actions-not-matching-rhetoric 2015-02-12T17:00:01+11:00 http://pharmadispatch.com/news/csl-reports-strong-growth-but-moderates-forecast 2015-02-12T17:00:01+11:00 http://pharmadispatch.com/news/patient-story-cant-be-dismissed 2015-02-12T17:00:01+11:00 http://pharmadispatch.com/news/new-listings 2015-02-13T17:00:01+11:00 http://pharmadispatch.com/news/guild-rejects-supermarket-attack-1 2015-02-13T17:00:01+11:00 http://pharmadispatch.com/news/critics-back-accc-backdown 2015-02-13T17:00:01+11:00 http://pharmadispatch.com/news/australian-study-in-stroke-breakthrough 2015-02-13T17:00:01+11:00 http://pharmadispatch.com/news/minister-hosts-pbs-meeting 2015-02-13T17:36:01+11:00 http://pharmadispatch.com/news/changes-at-the-top-making-things-difficult 2015-02-16T17:00:01+11:00 http://pharmadispatch.com/news/inside-story-from-pbs-meeting 2015-02-16T17:00:01+11:00 http://pharmadispatch.com/news/everyone-waiting-on-pbac 2015-02-16T17:00:01+11:00 http://pharmadispatch.com/news/halton-warns-on-health-costs 2015-02-16T17:00:01+11:00 http://pharmadispatch.com/news/nz-takes-it-to-another-level 2015-02-16T17:00:01+11:00 http://pharmadispatch.com/news/pbs-growth-higher-than-expected 2015-02-17T17:00:01+11:00 http://pharmadispatch.com/news/a-new-era-begins 2015-02-17T17:00:01+11:00 http://pharmadispatch.com/news/claims-highly-political-and-fanciful 2015-02-17T17:00:01+11:00 http://pharmadispatch.com/news/bayer-seeks-expanded-listing-for-eylea 2015-02-17T17:00:01+11:00 http://pharmadispatch.com/news/europe-leads-the-way-in-approving-first-mab-biosimilar 2015-02-18T17:00:01+11:00 http://pharmadispatch.com/news/slow-progress-on-pricing-of-new-presentations 2015-02-18T17:00:01+11:00 http://pharmadispatch.com/news/it-was-all-over-by-the-end-of-2013 2015-02-18T17:00:01+11:00 http://pharmadispatch.com/news/canspeak-we-cant-afford-to-wait 2015-02-18T17:00:01+11:00 http://pharmadispatch.com/news/another-company-walks-over-pricing 2015-02-19T17:00:01+11:00 http://pharmadispatch.com/news/a-new-reality 2015-02-19T17:00:01+11:00 http://pharmadispatch.com/news/gmia-action-required-on-biosimilars 2015-02-19T17:00:01+11:00 http://pharmadispatch.com/news/non-adherence-a-major-issue-says-nps 2015-02-20T05:00:01+11:00 http://pharmadispatch.com/news/chf-targets-pricing-and-pharmacy 2015-02-19T17:00:01+11:00 http://pharmadispatch.com/news/surprise-change 2015-02-20T17:00:01+11:00 http://pharmadispatch.com/news/guild-look-to-pharmacy-on-adherence 2015-02-20T17:00:01+11:00 http://pharmadispatch.com/news/no-submission-from-cancer-australia 2015-02-20T17:00:01+11:00 http://pharmadispatch.com/news/focus-on-misuse 2015-02-20T17:00:01+11:00 http://pharmadispatch.com/news/is-generic-substitution-high-enough 2015-02-23T17:00:01+11:00 http://pharmadispatch.com/news/budget-key-for-nps 2015-02-23T17:00:01+11:00 http://pharmadispatch.com/news/biogen-welcomes-ms-listing 2015-02-23T17:00:01+11:00 http://pharmadispatch.com/news/ama-opposes-discount-flu-vax 2015-02-23T17:00:01+11:00 http://pharmadispatch.com/news/valeant-still-chasing-acquisitions 2015-02-23T17:00:01+11:00 http://pharmadispatch.com/news/the-trade-agreement-fallacy 2015-02-24T17:00:01+11:00 http://pharmadispatch.com/news/department-takes-another-look 2015-02-24T17:00:01+11:00 http://pharmadispatch.com/news/patients-go-personal 2015-02-24T17:00:01+11:00 http://pharmadispatch.com/news/not-much-time-for-pbs 2015-02-24T17:00:01+11:00 http://pharmadispatch.com/news/asmi-welcomes-review 2015-02-24T17:00:01+11:00 http://pharmadispatch.com/news/teva-set-for-launch 2015-02-25T17:00:01+11:00 http://pharmadispatch.com/news/guild-calls-for-change 2015-02-25T17:00:01+11:00 http://pharmadispatch.com/news/australia-falling-behind 2015-02-25T16:00:01+11:00 http://pharmadispatch.com/news/zalcberg-government-must-recognise-the-problem 2015-02-25T17:00:01+11:00 http://pharmadispatch.com/news/orphan-designation-for-links-paser 2015-02-25T17:00:01+11:00 http://pharmadispatch.com/news/federal-court-backs-pfizer-against-accc 2015-02-26T00:03:01+11:00 http://pharmadispatch.com/news/industry-exec-appointed-nps-chair 2015-02-26T13:59:01+11:00 http://pharmadispatch.com/news/conditional-recommendations-not-allowed 2015-02-26T04:18:01+11:00 http://pharmadispatch.com/news/its-all-semantics-on-conditions 2015-02-26T16:00:01+11:00 http://pharmadispatch.com/news/healthcare-drives-ebos 2015-02-26T15:41:01+11:00 http://pharmadispatch.com/news/what-does-that-even-mean 2015-02-26T16:00:01+11:00 http://pharmadispatch.com/news/companies-were-circling-the-prey 2015-02-27T17:00:01+11:00 http://pharmadispatch.com/news/ma-action-needed-now 2015-02-27T04:24:01+11:00 http://pharmadispatch.com/news/making-an-already-difficult-situation-worse 2015-02-27T17:00:01+11:00 http://pharmadispatch.com/news/companies-were-circling-the-prey-1 2015-02-27T17:57:01+11:00 http://pharmadispatch.com/news/piwg-euthanased 2015-03-02T17:00:01+11:00 http://pharmadispatch.com/news/nz-patients-not-enough-funding 2015-03-02T17:00:01+11:00 http://pharmadispatch.com/news/time-to-modernise-pbs 2015-03-02T17:00:01+11:00 http://pharmadispatch.com/news/clinician-welcomes-new-schizophrenia-option 2015-03-02T17:00:01+11:00 http://pharmadispatch.com/news/audit-on-the-way 2015-03-03T17:00:01+11:00 http://pharmadispatch.com/news/brindell-a-lot-has-changed 2015-03-02T17:00:01+11:00 http://pharmadispatch.com/news/robb-anti-trade-groups-peddling-pbs-nonsense 2015-03-03T17:00:01+11:00 http://pharmadispatch.com/news/attention-turning-to-pbs-co-pays 2015-03-03T17:00:01+11:00 http://pharmadispatch.com/news/ato-targets-pharma 2015-03-03T17:00:01+11:00 http://pharmadispatch.com/news/bayer-responds-to-patients 2015-03-03T17:00:01+11:00 http://pharmadispatch.com/news/rex-complexity-with-multiple-layers 2015-03-04T17:00:01+11:00 http://pharmadispatch.com/news/janssen-highlights-its-own-experience 2015-03-03T17:00:01+11:00 http://pharmadispatch.com/news/faster-cabinet-approvals 2015-03-04T17:00:01+11:00 http://pharmadispatch.com/news/govt-softens-on-pbs-co-pay 2015-03-04T17:00:01+11:00 http://pharmadispatch.com/news/gsk-divests-opiates-business 2015-03-04T17:00:01+11:00 http://pharmadispatch.com/news/they-cant-really-believe-this 2015-03-04T17:00:01+11:00 http://pharmadispatch.com/news/xenophon-backs-pharmacy 2015-03-05T17:00:01+11:00 http://pharmadispatch.com/news/why-the-igr-is-so-important 2015-03-05T17:00:01+11:00 http://pharmadispatch.com/news/bi-to-submit-pradaxa-antidote 2015-03-05T17:00:01+11:00 http://pharmadispatch.com/news/new-ibd-resource-for-patients 2015-03-05T17:00:01+11:00 http://pharmadispatch.com/news/greens-want-australian-nice 2015-03-05T17:00:01+11:00 http://pharmadispatch.com/news/novartis-tiered-co-pays-for-high-cost-medicines 2015-03-05T17:27:01+11:00 http://pharmadispatch.com/news/janssen-secures-infliximab-in-nz 2015-03-05T17:05:01+11:00 http://pharmadispatch.com/news/hcv-a-rare-disease-in-ten-years 2015-03-10T17:00:01+11:00 http://pharmadispatch.com/news/accc-targets-nurofen-packaging 2015-03-06T17:00:01+11:00 http://pharmadispatch.com/news/igr-buys-into-slowing-growth 2015-03-05T20:52:01+11:00 http://pharmadispatch.com/news/sector-welcomes-igr 2015-03-06T17:00:01+11:00 http://pharmadispatch.com/news/anao-wants-cpa-changes 2015-03-06T17:00:01+11:00 http://pharmadispatch.com/news/abbvie-pays-us21-billion-for-pharmacyclics 2015-03-06T17:00:01+11:00 http://pharmadispatch.com/news/what-a-day 2015-03-06T17:00:01+11:00 http://pharmadispatch.com/news/record-fda-approval-for-bms-cancer-therapy 2015-03-06T17:00:01+11:00 http://pharmadispatch.com/news/what-a-day-1 2015-03-06T17:51:01+11:00 http://pharmadispatch.com/news/political-tit-for-tat-over-cpa-audit 2015-03-09T17:00:01+11:00 http://pharmadispatch.com/news/new-biosimilar-study 2015-03-09T17:00:01+11:00 http://pharmadispatch.com/news/new-venture-for-ex-ma-board-member 2015-03-09T17:00:01+11:00 http://pharmadispatch.com/news/pbac-shift-on-cancer-medicines 2015-03-09T17:00:01+11:00 http://pharmadispatch.com/news/prostate-cancer 2015-03-09T17:00:01+11:00 http://pharmadispatch.com/news/limitations-on-who-can-be-pbac-chair 2015-03-09T17:00:01+11:00 http://pharmadispatch.com/news/cabinet-queue-set-to-grow 2015-03-10T17:00:01+11:00 http://pharmadispatch.com/news/underlying-growth-for-aspen-australia 2015-03-11T05:00:01+11:00 http://pharmadispatch.com/news/you-cant-have-the-prices-without-the-consequences 2015-03-11T17:00:01+11:00 http://pharmadispatch.com/news/asmi-supplements-for-calcium-deficiency 2015-03-11T17:00:01+11:00 http://pharmadispatch.com/news/news-prices-another-blow-to-benchmarkers 2015-03-11T17:00:01+11:00 http://pharmadispatch.com/news/tga-hits-kpis-in-latest-report 2015-03-11T17:00:01+11:00 http://pharmadispatch.com/news/gilead-sovaldi-meets-listing-criteria 2015-03-11T17:00:01+11:00 http://pharmadispatch.com/news/rca-appoints-ex-pfizer-exec 2015-03-12T17:00:01+11:00 http://pharmadispatch.com/news/critics-using-audit-to-for-anti-guild-agenda 2015-03-12T17:00:01+11:00 http://pharmadispatch.com/news/nhmrc-it-doesnt-work-1 2015-03-12T17:00:01+11:00 http://pharmadispatch.com/news/recall-over-packaging-issues 2015-03-12T17:00:01+11:00 http://pharmadispatch.com/news/medicines-australia-education-awards 2015-03-12T17:00:01+11:00 http://pharmadispatch.com/news/msds-keytruda-wins-accelerated-approval-in-the-uk 2015-03-12T17:00:01+11:00 http://pharmadispatch.com/news/price-disclosure-threatens-access 2015-03-12T16:49:01+11:00 http://pharmadispatch.com/news/boost-for-pharmaxis 2015-03-12T22:04:01+11:00 http://pharmadispatch.com/news/sussan-ley-give-me-options-on-pbs 2015-03-13T17:00:01+11:00 http://pharmadispatch.com/news/what-about-a-united-front 2015-03-13T16:40:01+11:00 http://pharmadispatch.com/news/az-scraps-price-agreement 2015-03-16T17:00:01+11:00 http://pharmadispatch.com/news/pbs-changes-and-new-listings-for-1-april 2015-03-16T17:00:01+11:00 http://pharmadispatch.com/news/figher-harder-xenophon-tells-pharmacy 2015-03-15T02:52:01+11:00 http://pharmadispatch.com/news/guild-hits-back 2015-03-16T17:00:01+11:00 http://pharmadispatch.com/news/minister-welcomes-consumers-to-pbac 2015-03-16T04:53:01+11:00 http://pharmadispatch.com/news/acc-highlights 2015-03-16T17:00:01+11:00 http://pharmadispatch.com/news/biosimilars-in-the-spotlight 2015-03-16T06:22:01+11:00 http://pharmadispatch.com/news/savings-locked-away 2015-03-17T17:00:01+11:00 http://pharmadispatch.com/news/psa-pharmacists-misrepresented-on-homeopathy 2015-03-17T17:00:01+11:00 http://pharmadispatch.com/news/groups-unite-to-reject-tpp-scare-campaign 2015-03-17T17:00:01+11:00 http://pharmadispatch.com/news/gmia-want-substitution-review 2015-03-17T17:00:01+11:00 http://pharmadispatch.com/news/sanofis-pcsk9-hits-endpoint 2015-03-17T17:13:01+11:00 http://pharmadispatch.com/news/pbs-growth-certain-to-accelerate 2015-03-18T17:00:01+11:00 http://pharmadispatch.com/news/exclusive-minister-to-announce-new-post-market-review-process 2015-03-18T17:00:01+11:00 http://pharmadispatch.com/news/zalcberg-set-to-highlight-his-own-experience 2015-03-18T17:00:01+11:00 http://pharmadispatch.com/news/australians-missing-out 2015-03-18T17:00:01+11:00 http://pharmadispatch.com/news/actavis-launches-new-osteoporosis-resource 2015-03-18T17:00:01+11:00 http://pharmadispatch.com/news/department-hits-back-on-cancer 2015-03-18T17:00:01+11:00 http://pharmadispatch.com/news/pharmacists-kicked-in-the-guts 2015-03-19T17:00:01+11:00 http://pharmadispatch.com/news/new-ceo-of-consumers-health-forum 2015-03-19T17:00:01+11:00 http://pharmadispatch.com/news/government-blames-companies-for-access-delays 2015-03-19T02:11:01+11:00 http://pharmadispatch.com/news/accc-to-appeal-pfizer-decision 2015-03-19T17:00:01+11:00 http://pharmadispatch.com/news/ma-chair-everything-is-negotiable-but 2015-03-19T17:00:01+11:00 http://pharmadispatch.com/news/sussan-ley-pbac-approved-25-billion-in-new-listings 2015-03-19T17:00:01+11:00 http://pharmadispatch.com/news/two-very-different-conversations 2015-03-19T17:00:01+11:00 http://pharmadispatch.com/news/sigma-focussed-on-growing-non-pbs-revenues 2015-03-20T17:00:01+11:00 http://pharmadispatch.com/news/chf-backs-faster-access 2015-03-20T17:00:01+11:00 http://pharmadispatch.com/news/no-backward-step-from-ley 2015-03-20T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-wider-access-to-prevanar 2015-03-20T17:00:01+11:00 http://pharmadispatch.com/news/maestro-takes-a-closer-look-at-compare 2015-03-23T17:00:01+11:00 http://pharmadispatch.com/news/compare-report-sparks-debate-in-nz 2015-03-23T17:00:01+11:00 http://pharmadispatch.com/news/nsw-to-scrap-co-pays 2015-03-23T17:00:01+11:00 http://pharmadispatch.com/news/abbvie-confirms-viekira-pak-for-july-pbac 2015-03-23T17:00:01+11:00 http://pharmadispatch.com/news/dusc-concern-over-crohns-disease 2015-03-23T17:00:01+11:00 http://pharmadispatch.com/news/tolmar-welcomes-new-prostate-cancer-guidelines 2015-03-24T17:00:01+11:00 http://pharmadispatch.com/news/pbac-blames-companies-for-delays 2015-03-24T17:00:01+11:00 http://pharmadispatch.com/news/does-pbac-have-any-place-in-political-debate 2015-03-25T05:00:01+11:00 http://pharmadispatch.com/news/australians-want-access 2015-03-23T17:00:01+11:00 http://pharmadispatch.com/news/clinicians-welcome-genzymes-lemtrada 2015-03-24T17:00:01+11:00 http://pharmadispatch.com/news/di-natale-to-open-rare-disease-summit 2015-03-24T17:00:01+11:00 http://pharmadispatch.com/news/new-brand-and-biosimilars-for-biogen 2015-03-24T17:00:01+11:00 http://pharmadispatch.com/news/new-co-chair-for-parliamentary-friends-group 2015-03-25T17:00:01+11:00 http://pharmadispatch.com/news/uncertainty-over-nsw-co-pay-move 2015-03-25T17:00:01+11:00 http://pharmadispatch.com/news/sandoz-pulls-chemo-drugs 2015-03-25T17:00:01+11:00 http://pharmadispatch.com/news/new-skin-cancer-report-shuns-access 2015-03-25T16:28:01+11:00 http://pharmadispatch.com/news/new-actavis-to-exit-australian-generics-market 2015-03-25T20:49:01+11:00 http://pharmadispatch.com/news/msd-halts-keytruda-trial 2015-03-26T17:00:01+11:00 http://pharmadispatch.com/news/only-very-small-survival-gains 2015-03-26T17:00:01+11:00 http://pharmadispatch.com/news/gsk-and-novartis-unite-on-leukaemia-listing 2015-03-26T17:00:01+11:00 http://pharmadispatch.com/news/quilty-de-link-prices-and-pharmacy-pay 2015-03-26T17:00:01+11:00 http://pharmadispatch.com/news/sun-completes-ranbaxy-acquisition 2015-03-26T17:00:01+11:00 http://pharmadispatch.com/news/government-shields-pbs-in-tpp 2015-03-27T17:00:01+11:00 http://pharmadispatch.com/news/di-natale-moves-again-on-pharmacy 2015-03-27T17:00:01+11:00 http://pharmadispatch.com/news/choosing-wisely-australia-advisory-group-chair 2015-03-28T05:00:01+11:00 http://pharmadispatch.com/news/code-authorisation-imminent 2015-03-27T17:11:01+11:00 http://pharmadispatch.com/news/10-billion-in-the-bank 2015-03-30T17:00:01+11:00 http://pharmadispatch.com/news/the-future-is-social 2015-03-30T17:00:01+11:00 http://pharmadispatch.com/news/its-as-if-the-savings-dont-even-exist 2015-03-30T17:00:01+11:00 http://pharmadispatch.com/news/privacy-commissioner-backs-accc 2015-03-30T17:00:01+11:00 http://pharmadispatch.com/news/dont-stop-advocating-di-natale-tells-summit 2015-03-30T17:00:01+11:00 http://pharmadispatch.com/news/savings-cuts-1-in-5-from-the-pbs 2015-03-31T17:00:01+11:00 http://pharmadispatch.com/news/corporate-tax-undermining-investment 2015-03-31T02:57:01+11:00 http://pharmadispatch.com/news/three-companies-fight-off-complaint 2015-03-31T17:00:01+11:00 http://pharmadispatch.com/news/teva-makes-acquisition 2015-03-31T17:00:01+11:00 http://pharmadispatch.com/news/amneal-acquires-actavis-generics-business 2015-03-31T21:06:01+11:00 http://pharmadispatch.com/news/guild-rejects-review-recommendations 2015-04-01T17:00:01+11:00 http://pharmadispatch.com/news/price-cuts-hit-pharmacy 2015-04-01T17:00:01+11:00 http://pharmadispatch.com/news/sanofi-pasteur-announces-arrival-of-new-flu-vaccine 2015-04-01T17:00:01+11:00 http://pharmadispatch.com/news/first-day-on-the-job-for-bayers-new-leadership 2015-04-01T17:00:01+11:00 http://pharmadispatch.com/news/competition-report-urges-caution-on-ip 2015-04-01T17:00:01+11:00 http://pharmadispatch.com/news/adrian-bootes 2015-04-13T16:00:01+10:00 http://pharmadispatch.com/news/government-distances-itself-from-harper 2015-04-02T17:00:01+11:00 http://pharmadispatch.com/news/could-piwg-get-another-chance 2015-04-02T01:28:01+11:00 http://pharmadispatch.com/news/medicine-exports-slump-to-ten-year-low 2015-04-02T17:00:01+11:00 http://pharmadispatch.com/news/minister-confrims-new-listings 2015-04-02T17:00:01+11:00 http://pharmadispatch.com/news/napwha-welcomes-viivs-triumeq 2015-04-02T17:00:01+11:00 http://pharmadispatch.com/news/ma-no-excel-for-transparency-reports 2015-04-02T17:15:01+11:00 http://pharmadispatch.com/news/first-changes-from-prescribing-review 2015-04-07T16:00:01+10:00 http://pharmadispatch.com/news/labor-welcomes-piwg-backflip 2015-04-07T16:00:01+10:00 http://pharmadispatch.com/news/pbs-changes-and-new-listings-for-1-may 2015-04-07T16:00:01+10:00 http://pharmadispatch.com/news/key-labor-senator-steps-down 2015-04-07T16:00:01+10:00 http://pharmadispatch.com/news/no-competition 2015-04-08T16:00:01+10:00 http://pharmadispatch.com/news/pharmaxis-announces-positive-trial-results 2015-04-08T16:00:01+10:00 http://pharmadispatch.com/news/more-chemotherapy-delistings 2015-04-08T16:00:01+10:00 http://pharmadispatch.com/news/a-completely-different-world 2015-04-09T16:00:01+10:00 http://pharmadispatch.com/news/quilty-slams-intellectually-lazy-review 2015-04-10T04:00:01+10:00 http://pharmadispatch.com/news/the-winners-in-2015-so-far 2015-04-09T16:00:01+10:00 http://pharmadispatch.com/news/carr-indecision-and-chaos-on-industry-policy 2015-04-09T16:00:01+10:00 http://pharmadispatch.com/news/minister-receives-first-tga-review-report 2015-04-10T16:00:01+10:00 http://pharmadispatch.com/news/psa-issues-call-to-action 2015-04-10T16:00:01+10:00 http://pharmadispatch.com/news/otsuka-takes-back-abilify-1 2015-04-10T03:40:01+10:00 http://pharmadispatch.com/news/more-industry-ma 2015-04-10T16:00:01+10:00 http://pharmadispatch.com/news/yervoy-registration-catches-up-with-pbs-listing 2015-04-13T16:00:01+10:00 http://pharmadispatch.com/news/chf-consumers-must-be-at-the-centre-of-new-primary-health-networ 2015-04-12T22:33:01+10:00 http://pharmadispatch.com/news/ley-set-budget-savings-target 2015-04-13T16:00:01+10:00 http://pharmadispatch.com/news/the-trap-has-been-set 2015-04-13T16:00:01+10:00 http://pharmadispatch.com/news/companies-sign-on-with-psa 2015-04-12T16:00:01+10:00 http://pharmadispatch.com/news/lsdp-could-cease 2015-04-13T16:00:01+10:00 http://pharmadispatch.com/news/half-of-all-pbac-submissions-had-at-least-on-significant-problem 2015-04-14T16:00:01+10:00 http://pharmadispatch.com/news/get-funding-pathways-right 2015-04-14T16:00:01+10:00 http://pharmadispatch.com/news/boost-for-mesoblast 2015-04-14T04:42:01+10:00 http://pharmadispatch.com/news/promotion-for-ex-novartis-australia-head 2015-04-14T16:00:01+10:00 http://pharmadispatch.com/news/government-targets-pbs-in-budget 2015-04-15T16:00:01+10:00 http://pharmadispatch.com/news/minister-invites-input-on-diabetes-strategy 2015-04-15T16:00:01+10:00 http://pharmadispatch.com/news/chf-backs-review-but-urges-caution 2015-04-15T16:00:01+10:00 http://pharmadispatch.com/news/strong-currency-hits-jj 2015-04-15T16:00:01+10:00 http://pharmadispatch.com/news/whats-under-consideration 2015-04-16T16:00:01+10:00 http://pharmadispatch.com/news/lundbeck-goes-private 2015-04-16T16:00:01+10:00 http://pharmadispatch.com/news/pharma-sets-sets-the-standard 2015-04-16T01:55:01+10:00 http://pharmadispatch.com/news/cancer-debate-set-for-hearing 2015-04-16T15:59:01+10:00 http://pharmadispatch.com/news/patients-dominate-senate-hearing 2015-04-16T16:00:01+10:00 http://pharmadispatch.com/news/haemophilia-patients-waiting-and-waiting 2015-04-17T16:00:01+10:00 http://pharmadispatch.com/news/mental-health-review-recommends-a-move-away-from-pbs 2015-04-17T16:00:01+10:00 http://pharmadispatch.com/news/pharmac-says-no-to-transparency 2015-04-17T16:47:01+10:00 http://pharmadispatch.com/news/budget-proposals-target-f1-medicines 2015-04-20T16:00:01+10:00 http://pharmadispatch.com/news/biologics-facing-price-cut 2015-04-20T16:00:01+10:00 http://pharmadispatch.com/news/three-weeks-that-will-shape-the-next-five-years 2015-04-20T16:00:01+10:00 http://pharmadispatch.com/news/tga-delivers-world-first-for-keytruda 2015-04-20T16:00:01+10:00 http://pharmadispatch.com/news/carrot-and-stick-on-immunisation 2015-04-20T16:00:01+10:00 http://pharmadispatch.com/news/mylan-confirms-teva-interest 2015-04-20T16:27:01+10:00 http://pharmadispatch.com/news/industry-takes-on-pbs-process 2015-04-20T18:33:01+10:00 http://pharmadispatch.com/news/rare-cancers-patients-have-suffered-from-systematic-neglect 2015-04-20T22:31:01+10:00 http://pharmadispatch.com/news/bdmards-price-cut-confirmed 2015-04-21T16:00:01+10:00 http://pharmadispatch.com/news/australia-uses-hta-to-delay-access69 2015-04-21T16:00:01+10:00 http://pharmadispatch.com/news/department-trialling-new-parallel-process-for-breakthrough-thera 2015-04-21T02:12:01+10:00 http://pharmadispatch.com/news/pbac-misses-at-senate-inquiry 2015-04-21T04:37:01+10:00 http://pharmadispatch.com/news/budget-d-day-approaching 2015-04-22T16:00:01+10:00 http://pharmadispatch.com/news/companies-are-using-parallel-process-for-cancer-medicines 2015-04-22T16:00:01+10:00 http://pharmadispatch.com/news/teva-us40bn-move-for-mylan 2015-04-22T16:00:01+10:00 http://pharmadispatch.com/news/amgen-tops-first-quarter-forecast 2015-04-22T16:06:01+10:00 http://pharmadispatch.com/news/new-leadership-for-astrazeneca 2015-04-22T19:00:01+10:00 http://pharmadispatch.com/news/lowest-cpi-drug-price-rise-in-two-decades 2015-04-22T22:52:01+10:00 http://pharmadispatch.com/news/across-the-board-price-cut 2015-04-23T16:00:01+10:00 http://pharmadispatch.com/news/roche-cancer-portfolio-drives-growth 2015-04-23T16:00:01+10:00 http://pharmadispatch.com/news/perrigio-says-no-to-mylan 2015-04-23T16:00:01+10:00 http://pharmadispatch.com/news/bi-expecting-moderate-growth 2015-04-23T16:00:01+10:00 http://pharmadispatch.com/news/gordon-naylor-to-lead-csls-global-flu-vaccine-business 2015-04-23T18:57:01+10:00 http://pharmadispatch.com/news/budget-deadline-day 2015-04-24T16:00:01+10:00 http://pharmadispatch.com/news/novartis-smaller-but-more-profitable 2015-04-25T04:04:01+10:00 http://pharmadispatch.com/news/cost-reductions-and-higher-prices-boost-lilly 2015-04-24T16:17:01+10:00 http://pharmadispatch.com/news/king-reinvest-savings-in-health 2015-04-24T16:10:01+10:00 http://pharmadispatch.com/news/march-pbac-outcomes 2015-04-24T23:10:01+10:00 http://pharmadispatch.com/news/listing-within-reach-says-msds-sellars 2015-04-27T16:00:01+10:00 http://pharmadispatch.com/news/ley-to-announce-pbac-guidelines-review 2015-04-25T17:11:01+10:00 http://pharmadispatch.com/news/pbac-says-yes-to-biosimilar-substitution 2015-04-27T16:00:01+10:00 http://pharmadispatch.com/news/recommendation-a-watershed-moment-1 2015-04-27T16:00:01+10:00 http://pharmadispatch.com/news/now-for-implementation 2015-04-27T16:00:01+10:00 http://pharmadispatch.com/news/az-and-celgene-partner-on-immunotherapies 2015-04-27T16:00:01+10:00 http://pharmadispatch.com/news/mandatory-price-cut-or-price-disclosure-change 2015-04-27T16:00:01+10:00 http://pharmadispatch.com/news/maestro-take-on-pbac-outcomes 2015-04-27T16:00:01+10:00 http://pharmadispatch.com/news/mylan-lifts-perrigio-bid 2015-04-27T16:00:01+10:00 http://pharmadispatch.com/news/australia-set-to-lead-the-world-on-biosimilars 2015-04-28T16:00:01+10:00 http://pharmadispatch.com/news/ley-pbs-talks-going-well 2015-04-27T19:52:01+10:00 http://pharmadispatch.com/news/from-awareness-to-activation-partnering-with-patients-for-medica 2015-04-27T21:41:01+10:00 http://pharmadispatch.com/news/pbac-guidelines-review-must-consider-wider-benefits 2015-04-27T22:14:01+10:00 http://pharmadispatch.com/news/pbs-savings-set-to-deliver-4-billion 2015-04-28T16:00:01+10:00 http://pharmadispatch.com/news/gmia-welcome-biosimilar-a-flagging 2015-04-29T02:10:01+10:00 http://pharmadispatch.com/news/the-2bn-cost-of-diabetic-macular-oedema 2015-04-28T16:00:01+10:00 http://pharmadispatch.com/news/new-ebook-on-partnering-with-patients 2015-04-28T16:00:01+10:00 http://pharmadispatch.com/news/mylan-says-no-to-teva 2015-04-28T16:22:01+10:00 http://pharmadispatch.com/news/dont-walk-away 2015-04-29T16:00:01+10:00 http://pharmadispatch.com/news/chf-backs-common-sense-on-delistings 2015-04-29T00:57:01+10:00 http://pharmadispatch.com/news/australians-back-pharmacy-ethics-and-honesty 2015-04-29T01:43:01+10:00 http://pharmadispatch.com/news/psa-warns-on-budget-cuts 2015-04-29T16:00:01+10:00 http://pharmadispatch.com/news/pharmacy-sales-boost-blackmores 2015-04-29T16:00:01+10:00 http://pharmadispatch.com/news/choosing-wisely-launches-with-strong-focus-on-medicines 2015-04-29T16:00:01+10:00 http://pharmadispatch.com/news/results-pfizer-merck-and-bms 2015-04-29T16:00:01+10:00 http://pharmadispatch.com/news/pbac-to-consider-remicade-biosimilar 2015-04-30T16:00:01+10:00 http://pharmadispatch.com/news/we-dont-need-your-agreement 2015-04-30T16:00:01+10:00 http://pharmadispatch.com/news/another-busy-agenda 2015-04-30T16:00:01+10:00 http://pharmadispatch.com/news/perrigio-rejects-third-mylan-bid 2015-04-30T14:39:01+10:00 http://pharmadispatch.com/news/astrazeneca-and-uniquest-announce-new-collaboration 2015-04-30T15:48:01+10:00 http://pharmadispatch.com/news/chf-change-of-heart 2015-05-01T16:00:01+10:00 http://pharmadispatch.com/news/gsk-transparency-on-2014-payments 2015-05-01T16:00:01+10:00 http://pharmadispatch.com/news/from-white-to-red 2015-05-02T04:25:01+10:00 http://pharmadispatch.com/news/industry-reaching-breaking-point 2015-05-01T16:00:01+10:00 http://pharmadispatch.com/news/sanofi-reports-higher-than-expected-profit 2015-05-01T16:06:01+10:00 http://pharmadispatch.com/news/the-ten-pbs-budget-measures 2015-05-04T16:00:01+10:00 http://pharmadispatch.com/news/industry-targeted-in-budget-process 2015-05-04T16:00:01+10:00 http://pharmadispatch.com/news/codeine-upscheduling-bad-medicine-bad-policy-bad-economics 2015-05-04T16:00:01+10:00 http://pharmadispatch.com/news/roche-tops-biologics-leader-board 2015-05-04T16:00:01+10:00 http://pharmadispatch.com/news/company-results-gilead 2015-05-04T16:00:01+10:00 http://pharmadispatch.com/news/wider-changes-to-pbs-safety-net 2015-05-04T16:00:01+10:00 http://pharmadispatch.com/news/disbelief-over-biosimilar-substitution 2015-05-04T22:33:01+10:00 http://pharmadispatch.com/news/40-million-diabetes-saving 2015-05-05T16:00:01+10:00 http://pharmadispatch.com/news/thanks-but-no-thanks 2015-05-06T16:00:01+10:00 http://pharmadispatch.com/news/guild-slams-mean-and-tricky-budget-proposal 2015-05-05T03:34:01+10:00 http://pharmadispatch.com/news/a-savings-measure-dressed-up-as-something-else 2015-05-05T16:00:01+10:00 http://pharmadispatch.com/news/amneal-completes-acquisition-of-actavis-generics-business 2015-05-05T16:01:01+10:00 http://pharmadispatch.com/news/tga-likely-to-back-substitution 2015-05-06T15:00:01+10:00 http://pharmadispatch.com/news/teva-still-pursuing-mylan 2015-05-06T15:44:01+10:00 http://pharmadispatch.com/news/tpp-almost-done 2015-05-06T16:07:01+10:00 http://pharmadispatch.com/news/di-natale-new-greens-leader 2015-05-06T22:51:01+10:00 http://pharmadispatch.com/news/biosimilars-breaking-down-traditional-divides 2015-05-07T16:00:01+10:00 http://pharmadispatch.com/news/cabinet-set-to-endorse-budget 2015-05-07T16:00:01+10:00 http://pharmadispatch.com/news/39-nces-registered-in-2014 2015-05-07T16:00:01+10:00 http://pharmadispatch.com/news/ma-budget-appeal-to-prime-minister 2015-05-07T16:00:01+10:00 http://pharmadispatch.com/news/how-did-it-get-to-this 2015-05-07T15:04:01+10:00 http://pharmadispatch.com/news/no-april-fools-jokes-for-industry-in-2016 2015-05-08T16:00:01+10:00 http://pharmadispatch.com/news/james-budget-reaction-unprecedented 2015-05-08T16:00:01+10:00 http://pharmadispatch.com/news/gsk-going-its-own-way 2015-05-08T15:14:01+10:00 http://pharmadispatch.com/news/minister-announces-13-billion-for-new-pbs-listings-and-a-vaccine 2015-05-09T15:45:01+10:00 http://pharmadispatch.com/news/new-listings-welcome-but 2015-05-09T21:03:01+10:00 http://pharmadispatch.com/news/changes-coming-to-the-department 2015-05-11T16:00:01+10:00 http://pharmadispatch.com/news/what-to-look-for-in-the-budget 2015-05-11T16:00:01+10:00 http://pharmadispatch.com/news/pharma-enters-post-mou-era 2015-05-11T16:00:01+10:00 http://pharmadispatch.com/news/different-paths-to-reimbursement 2015-05-11T16:00:01+10:00 http://pharmadispatch.com/news/dont-blame-us-department-tells-industry 2015-05-12T16:00:01+10:00 http://pharmadispatch.com/news/guild-mocks-189-billion-claim 2015-05-12T16:00:01+10:00 http://pharmadispatch.com/news/enough-is-enough-on-organ-donation 2015-05-12T16:00:01+10:00 http://pharmadispatch.com/news/no-need-for-pharmacy-in-supermarkets 2015-05-12T16:00:01+10:00 http://pharmadispatch.com/news/govt-announces-budget-cancer-package 2015-05-12T16:00:01+10:00 http://pharmadispatch.com/news/tga-approves-harvoni-1 2015-05-12T15:37:01+10:00 http://pharmadispatch.com/news/government-ready-to-go-on-savings-but-wants-agreement 2015-05-13T05:35:01+10:00 http://pharmadispatch.com/news/the-announced-measures 2015-05-13T05:37:01+10:00 http://pharmadispatch.com/news/get-ready-for-the-pasp 2015-05-13T16:00:01+10:00 http://pharmadispatch.com/news/pbs-forecast-revised-up-again 2015-05-13T14:22:01+10:00 http://pharmadispatch.com/news/sector-responds-to-the-budget 2015-05-13T15:12:01+10:00 http://pharmadispatch.com/news/many-australians-in-the-dark-on-schizophrenia 2015-05-13T15:30:01+10:00 http://pharmadispatch.com/news/research-sector-welcomes-mrff-commitment 2015-05-13T15:48:01+10:00 http://pharmadispatch.com/news/pharmacy-edges-closer-to-agreement 2015-05-14T16:00:01+10:00 http://pharmadispatch.com/news/new-agreement-for-nps-medicinewise 2015-05-14T16:00:01+10:00 http://pharmadispatch.com/news/budget-silence-not-a-rejection-of-hepatitis-c-therapy-funding 2015-05-14T16:00:01+10:00 http://pharmadispatch.com/news/bowles-announces-major-changes 2015-05-14T15:32:01+10:00 http://pharmadispatch.com/news/stop-wasting-the-ministers-time-industry-told 2015-05-15T16:00:01+10:00 http://pharmadispatch.com/news/labor-wants-higher-rd-spending 2015-05-15T16:00:01+10:00 http://pharmadispatch.com/news/last-day-of-edition-17 2015-05-15T16:00:01+10:00 http://pharmadispatch.com/news/transformation-impacts-gsk-2014-result 2015-05-15T16:00:01+10:00 http://pharmadispatch.com/news/guild-secures-agreement-but-ma-misses-out 2015-05-16T20:40:01+10:00 http://pharmadispatch.com/news/very-different-outlooks 2015-05-18T16:00:01+10:00 http://pharmadispatch.com/news/pbs-share-of-health-starts-to-rise 2015-05-18T16:00:01+10:00 http://pharmadispatch.com/news/previously-delisted-drug-reappears 2015-05-18T16:00:01+10:00 http://pharmadispatch.com/news/securing-a-pbs-listing-in-the-current-political-environment 2015-05-18T16:00:01+10:00 http://pharmadispatch.com/news/ma-wants-balance-and-equity 2015-05-18T16:00:01+10:00 http://pharmadispatch.com/news/guild-confirms-agreement 2015-05-18T15:43:01+10:00 http://pharmadispatch.com/news/pharmaxis-soars-on-bi-deal 2015-05-19T16:00:01+10:00 http://pharmadispatch.com/news/any-access-delay-puts-patients-at-risk 2015-05-19T16:00:01+10:00 http://pharmadispatch.com/news/stakeholders-welcome-6cpa-progress 2015-05-19T16:00:01+10:00 http://pharmadispatch.com/news/nominations-open-for-research-australia-awards 2015-05-19T16:00:01+10:00 http://pharmadispatch.com/news/gmia-quiet-on-agreement 2015-05-19T16:00:01+10:00 http://pharmadispatch.com/news/patients-need-consistent-advice-on-corticosteroids 2015-05-19T16:00:01+10:00 http://pharmadispatch.com/news/ma-recruits-ex-abbott-staffer 2015-05-19T16:00:01+10:00 http://pharmadispatch.com/news/ma-not-going-quietly-on-agreement 2015-05-20T01:23:01+10:00 http://pharmadispatch.com/news/leo-pulls-product-from-pbs 2015-05-20T02:06:01+10:00 http://pharmadispatch.com/news/ama-criticising-its-own-process 2015-05-20T15:25:01+10:00 http://pharmadispatch.com/news/ministers-launch-new-clinical-trials-website 2015-05-21T16:00:01+10:00 http://pharmadispatch.com/news/shpa-announces-ceo-departure 2015-05-21T16:00:01+10:00 http://pharmadispatch.com/news/tpp-trigger-moves-closer 2015-05-21T15:54:01+10:00 http://pharmadispatch.com/news/minister-defends-pbs-as-ma-launches-public-campaign 2015-05-21T19:51:01+10:00 http://pharmadispatch.com/news/relationship-tested-like-never-before 2015-05-22T16:00:01+10:00 http://pharmadispatch.com/news/minister-starts-clearing-the-decks-on-pbs 2015-05-22T16:00:01+10:00 http://pharmadispatch.com/news/another-1bn-added-to-pbs-savings-target 2015-05-22T15:41:01+10:00 http://pharmadispatch.com/news/tpp-boosted-by-us-senate-vote 2015-05-22T16:13:01+10:00 http://pharmadispatch.com/news/wilson-the-popular-choice 2015-05-25T16:00:01+10:00 http://pharmadispatch.com/news/ma-hits-pause-pbs-campaign 2015-05-25T16:00:01+10:00 http://pharmadispatch.com/news/sanofi-seeks-funding-for-gp-diabetes-training 2015-05-25T16:00:01+10:00 http://pharmadispatch.com/news/well-known-names-reappear-with-strides-acquisition 2015-05-25T16:00:01+10:00 http://pharmadispatch.com/news/janssens-imbruvica-set-for-pbac 2015-05-25T16:00:01+10:00 http://pharmadispatch.com/news/volume-down-cost-up-1 2015-05-26T16:00:01+10:00 http://pharmadispatch.com/news/gmia-refocussed-and-regenerated 2015-05-26T16:00:01+10:00 http://pharmadispatch.com/news/di-natale-sticks-with-health 2015-05-26T16:00:01+10:00 http://pharmadispatch.com/news/pbs-savings-package-imminent 2015-05-26T02:25:01+10:00 http://pharmadispatch.com/news/coalition-backs-pbs-changes 2015-05-27T00:47:01+10:00 http://pharmadispatch.com/news/coming-down-to-the-final-hours 2015-05-27T16:00:01+10:00 http://pharmadispatch.com/news/federal-court-backs-rb-in-gsk-patent-dispute 2015-05-27T16:00:01+10:00 http://pharmadispatch.com/news/labor-pathetic-cruel-and-heartless 2015-05-27T16:00:01+10:00 http://pharmadispatch.com/news/biosimilar-changes-could-surprise 2015-05-27T16:09:01+10:00 http://pharmadispatch.com/news/gmia-and-guild-agreements 2015-05-27T17:58:01+10:00 http://pharmadispatch.com/news/minister-confirms-industry-rep-for-pbac 2015-05-27T19:59:01+10:00 http://pharmadispatch.com/news/the-package 2015-05-27T21:34:01+10:00 http://pharmadispatch.com/news/time-will-tell-on-biosimilars 2015-05-28T16:00:01+10:00 http://pharmadispatch.com/news/biogen-greets-oceans-of-hope-yacht-ahead-of-world-ms-day 2015-05-28T16:00:01+10:00 http://pharmadispatch.com/news/government-acts-to-establish-mrff 2015-05-28T16:00:01+10:00 http://pharmadispatch.com/news/wholesalers-welcome-6cpa 2015-05-28T03:35:01+10:00 http://pharmadispatch.com/news/pbac-sets-delisting-principles 2015-05-28T16:03:01+10:00 http://pharmadispatch.com/news/claims-industry-misled-on-biosimilars 2015-05-29T16:00:01+10:00 http://pharmadispatch.com/news/representing-the-most-important-group-of-all 2015-05-29T00:15:01+10:00 http://pharmadispatch.com/news/tremendous-sense-of-disappointment-over-pbac-comments 2015-05-29T16:00:01+10:00 http://pharmadispatch.com/news/novartis-wins-symbion-engage-award 2015-05-29T16:00:01+10:00 http://pharmadispatch.com/news/australia-not-the-only-country-dealing-with-biosimilars 2015-05-29T16:00:01+10:00 http://pharmadispatch.com/news/minister-announces-another-new-listing 2015-05-31T17:55:01+10:00 http://pharmadispatch.com/news/the-decade-of-no-growth 2015-06-01T20:48:01+10:00 http://pharmadispatch.com/news/a-list-full-of-generics 2015-06-01T16:00:01+10:00 http://pharmadispatch.com/news/teva-building-stake-in-mylan 2015-06-01T16:00:01+10:00 http://pharmadispatch.com/news/bms-and-msd-report-on-immunotherapies 2015-06-01T16:00:01+10:00 http://pharmadispatch.com/news/merck-serono-welcomes-expanded-listing-for-erbitux 2015-06-01T16:00:01+10:00 http://pharmadispatch.com/news/pbac-cautious-on-triple-combinations 2015-06-01T16:00:01+10:00 http://pharmadispatch.com/news/we-will-do-better-bowles-tells-senate 2015-06-02T16:00:01+10:00 http://pharmadispatch.com/news/positive-results-for-bayers-stivarga-in-gastro-intestinal-cancer 2015-06-02T16:00:01+10:00 http://pharmadispatch.com/news/boost-for-bms-immunotherapy-combination 2015-06-02T16:00:01+10:00 http://pharmadispatch.com/news/confusion-over-pbs-co-pays 2015-06-02T16:00:01+10:00 http://pharmadispatch.com/news/national-strategy-to-address-antibiotic-overuse 2015-06-02T16:58:01+10:00 http://pharmadispatch.com/news/pharmacy-and-biosimilars-dominate-senate-discussion 2015-06-02T18:47:01+10:00 http://pharmadispatch.com/news/its-a-complex-issue 2015-06-03T16:00:01+10:00 http://pharmadispatch.com/news/stop-playing-games-mylan-tells-teva 2015-06-03T16:00:01+10:00 http://pharmadispatch.com/news/ato-pbs-hits-company-profits 2015-06-03T16:00:01+10:00 http://pharmadispatch.com/news/government-pushes-pbs-legislation 2015-06-03T06:27:01+10:00 http://pharmadispatch.com/news/nps-backs-antibiotics-strategy 2015-06-03T16:00:01+10:00 http://pharmadispatch.com/news/department-wrong-on-quebec 2015-06-04T16:00:01+10:00 http://pharmadispatch.com/news/i-learnt-a-new-word-monopsony-says-tax-commissioner 2015-06-03T23:27:01+10:00 http://pharmadispatch.com/news/just-eight-days-left 2015-06-04T16:00:01+10:00 http://pharmadispatch.com/news/tgas-new-annual-charge-exemption-scheme 2015-06-04T16:27:01+10:00 http://pharmadispatch.com/news/a-change-of-emphasis-on-biosimilars 2015-06-05T16:00:01+10:00 http://pharmadispatch.com/news/department-of-health-respond-on-biosimilars 2015-06-05T16:00:01+10:00 http://pharmadispatch.com/news/tga-backs-noacs-on-blood-monitoring 2015-06-05T16:00:01+10:00 http://pharmadispatch.com/news/its-all-in-a-name 2015-06-05T16:00:01+10:00 http://pharmadispatch.com/news/nejm-published-vytorin-study 2015-06-05T16:01:01+10:00 http://pharmadispatch.com/news/wholesalers-happy-but-looking-to-review 2015-06-09T16:00:01+10:00 http://pharmadispatch.com/news/more-recognition-for-jane-halton 2015-06-09T16:00:01+10:00 http://pharmadispatch.com/news/teva-prepares-to-make-proposal 2015-06-09T16:00:01+10:00 http://pharmadispatch.com/news/pbs-changes-set-to-face-senate-scrutiny 2015-06-09T16:00:01+10:00 http://pharmadispatch.com/news/study-backs-januvia-safety 2015-06-10T16:00:01+10:00 http://pharmadispatch.com/news/the-winners-in-2015-so-far-1 2015-06-10T16:00:01+10:00 http://pharmadispatch.com/news/ma-use-higher-gst-to-attract-investment 2015-06-10T16:00:01+10:00 http://pharmadispatch.com/news/pharmacists-urged-to-support-bowel-cancer-awareness-month 2015-06-10T16:00:01+10:00 http://pharmadispatch.com/news/tolmar-announces-details-of-uro-oncology-symposium 2015-06-10T16:00:01+10:00 http://pharmadispatch.com/news/bms-recognised-as-a-best-employer 2015-06-11T16:00:01+10:00 http://pharmadispatch.com/news/guild-pbs-bill-faces-extremely-tight-timetable 2015-06-11T16:00:01+10:00 http://pharmadispatch.com/news/ex-chf-chair-says-no-to-biosimilar-substitution 2015-06-11T16:00:01+10:00 http://pharmadispatch.com/news/entering-the-policy-super-cycle 2015-06-11T03:02:01+10:00 http://pharmadispatch.com/news/transparency-for-some-but-not-all 2015-06-11T16:06:01+10:00 http://pharmadispatch.com/news/scrap-innovation-patent-system 2015-06-11T16:00:01+10:00 http://pharmadispatch.com/news/gmia-substitution-only-part-of-the-story 2015-06-12T16:00:01+10:00 http://pharmadispatch.com/news/no-pbs-at-new-health-industry-forum 2015-06-12T16:00:01+10:00 http://pharmadispatch.com/news/mylan-novartis-or-pfizer-preferred-buyers 2015-06-12T16:09:01+10:00 http://pharmadispatch.com/news/bayer-sells-diabetes-care-business 2015-06-12T03:08:01+10:00 http://pharmadispatch.com/news/biosimilars-the-interchangeability-debate 2015-06-15T16:00:01+10:00 http://pharmadispatch.com/news/minister-told-to-wait-for-the-evidence 2015-06-15T16:00:01+10:00 http://pharmadispatch.com/news/pbs-bill-scheduled-for-debate-today 2015-06-15T16:00:01+10:00 http://pharmadispatch.com/news/gsk-backed-campaign-to-raise-awareness-of-prostate-risks 2015-06-15T16:00:01+10:00 http://pharmadispatch.com/news/fda-advised-to-approve-cholesterol-lowering-biologics 2015-06-15T16:00:01+10:00 http://pharmadispatch.com/news/staff-changes-for-sussan-ley 2015-06-16T16:00:01+10:00 http://pharmadispatch.com/news/confronting-hep-c-stigma-in-pursuit-of-a-cure 2015-06-16T16:00:01+10:00 http://pharmadispatch.com/news/a-new-home-for-pharma-and-biotech-recruitment 2015-06-16T16:00:01+10:00 http://pharmadispatch.com/news/csl-lower-tax-to-attract-investment 2015-06-16T16:00:01+10:00 http://pharmadispatch.com/news/labor-backs-a-closer-look-at-pbs-changes 2015-06-16T16:00:01+10:00 http://pharmadispatch.com/news/nps-go-back-to-your-doctor 2015-06-16T16:00:01+10:00 http://pharmadispatch.com/news/anti-industry-mp-at-it-again 2015-06-16T16:00:01+10:00 http://pharmadispatch.com/news/the-pbs-debate 2015-06-16T15:37:01+10:00 http://pharmadispatch.com/news/government-announces-new-chemo-funding-package 2015-06-16T16:26:01+10:00 http://pharmadispatch.com/news/new-cancer-listings-but-tougher-prescribing-for-fertility-drugs 2015-06-17T16:00:01+10:00 http://pharmadispatch.com/news/pbs-bill-senate-agrees-to-a-close-look 2015-06-17T16:00:01+10:00 http://pharmadispatch.com/news/innovation-required-in-prostate-cancer-treatment 2015-06-17T16:00:01+10:00 http://pharmadispatch.com/news/ma-dont-scrap-orphan-drug-fee-waiver 2015-06-17T16:00:01+10:00 http://pharmadispatch.com/news/abbott-labs-backs-mylan 2015-06-17T16:30:01+10:00 http://pharmadispatch.com/news/merck-ceo-cautions-australia-on-access-and-pricing 2015-06-18T01:29:01+10:00 http://pharmadispatch.com/news/rheumatologist-voice-switching-concerns 2015-06-18T16:00:01+10:00 http://pharmadispatch.com/news/non-government-sectors-get-one-hour 2015-06-18T16:00:01+10:00 http://pharmadispatch.com/news/another-listing-for-az-diabetes-drug 2015-06-18T16:00:01+10:00 http://pharmadispatch.com/news/frazier-australia-could-be-a-dominant-power-in-medicines 2015-06-18T16:00:01+10:00 http://pharmadispatch.com/news/joe-demarte-elected-psa-national-president 2015-06-18T16:00:01+10:00 http://pharmadispatch.com/news/government-promotes-benefits-of-new-fta 2015-06-18T16:00:01+10:00 http://pharmadispatch.com/news/csl-acquires-rights-to-intravenous-flu-drug 2015-06-18T16:52:01+10:00 http://pharmadispatch.com/news/australians-travelling-for-clinical-trials 2015-06-19T16:00:01+10:00 http://pharmadispatch.com/news/biosimilars-dominate-senate-discussion 2015-06-18T21:54:01+10:00 http://pharmadispatch.com/news/pbac-clarifies-position-on-biosimilars 2015-06-19T05:30:01+10:00 http://pharmadispatch.com/news/pbac-safety-of-biosimilar-medicines 2015-06-19T05:30:01+10:00 http://pharmadispatch.com/news/pharmacy-urges-senate-support-for-pbs-bill 2015-06-19T16:00:01+10:00 http://pharmadispatch.com/news/1-october-price-cuts 2015-06-19T16:00:01+10:00 http://pharmadispatch.com/news/agreement-deadline-extended 2015-06-19T16:30:01+10:00 http://pharmadispatch.com/news/common-sense-should-prevail 2015-06-22T16:00:01+10:00 http://pharmadispatch.com/news/pharma-companies-to-front-tax-inquiry 2015-06-22T16:00:01+10:00 http://pharmadispatch.com/news/another-extension-to-cancer-inquiry-reporting-date 2015-06-23T04:00:01+10:00 http://pharmadispatch.com/news/senate-inquiry-into-mrff 2015-06-22T16:00:01+10:00 http://pharmadispatch.com/news/changes-at-the-guild 2015-06-22T16:00:01+10:00 http://pharmadispatch.com/news/mixed-messages-on-pbs 2015-06-22T16:00:01+10:00 http://pharmadispatch.com/news/biosimilar-debate-still-going 2015-06-22T16:00:01+10:00 http://pharmadispatch.com/news/a-boost-for-self-care 2015-06-23T16:00:01+10:00 http://pharmadispatch.com/news/pbac-sets-date-for-biosimilar-forum 2015-06-23T16:00:01+10:00 http://pharmadispatch.com/news/ma-urges-caution-on-corporate-tax-reform 2015-06-23T16:00:01+10:00 http://pharmadispatch.com/news/gmia-where-is-the-patient-safety-issue 2015-06-23T16:00:01+10:00 http://pharmadispatch.com/news/ma-grattan-institute-misses-the-point-again 2015-06-23T16:00:01+10:00 http://pharmadispatch.com/news/bi-confirms-tga-submission-for-pradaxa-antidote 2015-06-24T16:00:01+10:00 http://pharmadispatch.com/news/government-walks-away-from-ma-agreement 2015-06-23T22:11:01+10:00 http://pharmadispatch.com/news/msd-grant-for-indigenous-health 2015-06-24T16:00:01+10:00 http://pharmadispatch.com/news/time-to-look-ahead 2015-06-24T16:00:01+10:00 http://pharmadispatch.com/news/minister-rejects-ma-criticism 2015-06-24T16:00:01+10:00 http://pharmadispatch.com/news/new-tga-guidelines-keep-it-simple 2015-06-24T16:00:01+10:00 http://pharmadispatch.com/news/pfizer-welcomes-xalkori-listing 2015-06-24T16:07:01+10:00 http://pharmadispatch.com/news/uk-says-use-cheapest-infliximab 2015-06-25T16:00:01+10:00 http://pharmadispatch.com/news/another-step-forward-for-tpp 2015-06-25T16:00:01+10:00 http://pharmadispatch.com/news/quilty-6cpa-meets-our-key-objectives 2015-06-25T16:00:01+10:00 http://pharmadispatch.com/news/trust-us-on-biosimilars-not-good-enough-says-ex-chf-chair 2015-06-25T16:00:01+10:00 http://pharmadispatch.com/news/tga-review-recommends-major-changes 2015-06-25T16:00:01+10:00 http://pharmadispatch.com/news/just-another-distraction 2015-06-25T22:00:01+10:00 http://pharmadispatch.com/news/ma-keen-to-work-with-government-on-access 2015-06-25T22:26:01+10:00 http://pharmadispatch.com/news/patients-warehoused-waiting-for-new-hcv-therapies 2015-06-26T15:02:01+10:00 http://pharmadispatch.com/news/us-senate-backs-trade-fast-track 2015-06-26T15:18:01+10:00 http://pharmadispatch.com/news/first-meeting-of-health-industry-forum 2015-06-26T15:36:01+10:00 http://pharmadispatch.com/news/new-price-change-dates-confirmed 2015-06-26T15:53:01+10:00 http://pharmadispatch.com/news/stakeholder-responses-to-tga-review-report 2015-06-26T16:04:01+10:00 http://pharmadispatch.com/news/concern-over-the-fate-of-protos 2015-06-26T21:52:01+10:00 http://pharmadispatch.com/news/biosimilars-it-just-got-more-confusing 2015-06-29T16:00:01+10:00 http://pharmadispatch.com/news/changes-for-some-hsd-medicines 2015-06-29T16:00:01+10:00 http://pharmadispatch.com/news/companies-consider-f1-options 2015-06-29T16:00:01+10:00 http://pharmadispatch.com/news/prime-minister-announces-listing-of-keytruda 2015-06-28T18:07:01+10:00 http://pharmadispatch.com/news/two-months-doesnt-sound-a-long-time 2015-06-29T16:00:01+10:00 http://pharmadispatch.com/news/add-a-flagging-to-listing-conditions 2015-06-30T16:00:01+10:00 http://pharmadispatch.com/news/novartis-acquires-australian-biotech-spinifex 2015-06-30T16:00:01+10:00 http://pharmadispatch.com/news/tga-approval-for-bms-hep-c-therapy 2015-06-30T16:00:01+10:00 http://pharmadispatch.com/news/industry-readies-for-tax-inquiry 2015-06-30T16:02:01+10:00 http://pharmadispatch.com/news/astrazeneca-tops-hcp-consultant-spend 2015-07-01T16:00:01+10:00 http://pharmadispatch.com/news/bayer-tops-hco-grants-list 2015-07-01T16:00:01+10:00 http://pharmadispatch.com/news/clinicians-welcome-new-lucentis-listing 2015-07-01T16:00:01+10:00 http://pharmadispatch.com/news/pbs-listing-for-new-breast-cancer-therapies 2015-07-01T16:00:01+10:00 http://pharmadispatch.com/news/concern-over-decline-in-screening-for-breast-cancer 2015-07-01T16:00:01+10:00 http://pharmadispatch.com/news/biogen-backed-ms-campaign 2015-07-01T16:00:01+10:00 http://pharmadispatch.com/news/pbs-adviser-move-to-department 2015-07-01T16:00:01+10:00 http://pharmadispatch.com/news/tax-inquiry-goes-largely-as-expected 2015-07-01T18:51:01+10:00 http://pharmadispatch.com/news/it-was-about-theatre-not-facts 2015-07-02T16:00:01+10:00 http://pharmadispatch.com/news/ato-the-issue-is-whether-companies-are-distributors 2015-07-02T16:00:01+10:00 http://pharmadispatch.com/news/psa-welcomes-support-for-pharmacists-in-general-practices 2015-07-02T16:00:01+10:00 http://pharmadispatch.com/news/opening-statement-from-pfizers-david-gallagher 2015-07-02T16:00:01+10:00 http://pharmadispatch.com/news/where-did-it-go-wrong 2015-07-03T16:00:01+10:00 http://pharmadispatch.com/news/az-inks-rd-agreement-with-university-of-adelaide 2015-07-03T16:00:01+10:00 http://pharmadispatch.com/news/ex-sigma-execs-plead-guilty 2015-07-03T16:00:01+10:00 http://pharmadispatch.com/news/novartis-facing-us33bn-claim 2015-07-03T16:00:01+10:00 http://pharmadispatch.com/news/company-did-not-request-biosimilar-a-flag 2015-07-06T16:00:01+10:00 http://pharmadispatch.com/news/pbac-documents-reveal-accelerated-consideration-of-msds-keytruda 2015-07-06T16:00:01+10:00 http://pharmadispatch.com/news/hard-spending-cap-on-new-hep-c-therapies 2015-07-06T16:00:01+10:00 http://pharmadispatch.com/news/procurement-dressed-up-as-science 2015-07-06T16:00:01+10:00 http://pharmadispatch.com/news/uni-of-adelaide-wins-guidelines-review 2015-07-06T16:00:01+10:00 http://pharmadispatch.com/news/a-shop-front-for-pricing-negotiations 2015-07-07T16:00:01+10:00 http://pharmadispatch.com/news/ma-kicks-off-code-education-campaign 2015-07-07T16:00:01+10:00 http://pharmadispatch.com/news/stakeholders-gather-for-biosimilar-consultation 2015-07-07T16:00:01+10:00 http://pharmadispatch.com/news/loss-for-australian-medical-research 2015-07-07T16:00:01+10:00 http://pharmadispatch.com/news/teva-set-to-formalise-mylan-takeover-bid 2015-07-07T16:26:01+10:00 http://pharmadispatch.com/news/labor-urges-ip-trade-review 2015-07-08T16:00:01+10:00 http://pharmadispatch.com/news/acrux-and-lilly-allege-axiron-patent-infringement 2015-07-08T16:00:01+10:00 http://pharmadispatch.com/news/time-to-take-control 2015-07-08T16:00:01+10:00 http://pharmadispatch.com/news/wilson-evidence-the-key-factor 2015-07-08T16:00:01+10:00 http://pharmadispatch.com/news/quilty-new-revenue-streams-essential 2015-07-09T16:00:01+10:00 http://pharmadispatch.com/news/ma-welcomed-university-research-review 2015-07-09T16:00:01+10:00 http://pharmadispatch.com/news/new-pharmacy-board-chair-welcomed 2015-07-09T16:00:01+10:00 http://pharmadispatch.com/news/stakeholders-need-clarity 2015-07-09T16:00:01+10:00 http://pharmadispatch.com/news/ma-stop-free-trade-hysteria 2015-07-10T16:00:01+10:00 http://pharmadispatch.com/news/novartis-welcomes-heart-failure-blockbuster 2015-07-10T16:00:01+10:00 http://pharmadispatch.com/news/ma-not-backing-down-on-corporate-tax 2015-07-10T16:00:01+10:00 http://pharmadispatch.com/news/amneal-signs-up-with-gmia 2015-07-10T16:00:01+10:00 http://pharmadispatch.com/news/guild-report-breaks-the-urban-myth 2015-07-10T16:00:01+10:00 http://pharmadispatch.com/news/push-for-australian-biosimilars-forum 2015-07-13T16:00:01+10:00 http://pharmadispatch.com/news/sanofi-working-towards-pbs-for-toujeo 2015-07-13T16:00:01+10:00 http://pharmadispatch.com/news/amgens-prolia-leading-the-way 2015-07-13T16:00:01+10:00 http://pharmadispatch.com/news/clinicians-should-have-final-say-on-biosimilars 2015-07-13T16:00:01+10:00 http://pharmadispatch.com/news/next-stop-hawaii-for-tpp 2015-07-13T16:00:01+10:00 http://pharmadispatch.com/news/new-market-access-head-for-amgen 2015-07-14T16:00:01+10:00 http://pharmadispatch.com/news/ma-mrff-needs-industry-backing 2015-07-14T16:00:01+10:00 http://pharmadispatch.com/news/psa-follow-britains-lead-on-gp-pharmacist-collaboration 2015-07-14T16:00:01+10:00 http://pharmadispatch.com/news/how-times-have-changed 2015-07-14T16:00:01+10:00 http://pharmadispatch.com/news/tga-approves-abbvie-hep-c-therapy 2015-07-14T16:06:01+10:00 http://pharmadispatch.com/news/department-finalising-pbac-member-nominating-bodies 2015-07-15T16:00:01+10:00 http://pharmadispatch.com/news/retail-script-market-still-falling 2015-07-15T16:00:01+10:00 http://pharmadispatch.com/news/asmi-calls-for-nominations 2015-07-15T16:00:01+10:00 http://pharmadispatch.com/news/tolmar-anzup-clinical-research-fellowship-goes-to-brisbane-oncol 2015-07-15T16:00:01+10:00 http://pharmadispatch.com/news/jj-beats-estimates-despite-currency 2015-07-15T16:00:01+10:00 http://pharmadispatch.com/news/evidence-backs-medication-reviews 2015-07-16T16:00:01+10:00 http://pharmadispatch.com/news/1-august-pbs-update 2015-07-16T16:00:01+10:00 http://pharmadispatch.com/news/new-country-manager-for-novartis 2015-07-16T16:00:01+10:00 http://pharmadispatch.com/news/pfizer-working-to-secure-approval-for-hospira-acquisition 2015-07-16T16:00:01+10:00 http://pharmadispatch.com/news/celgene-acquires-receptos-for-us72bn 2015-07-16T15:21:01+10:00 http://pharmadispatch.com/news/grattan-at-it-again 2015-07-17T16:00:01+10:00 http://pharmadispatch.com/news/pfizer-confirms-new-contract-for-prevenar-13 2015-07-17T16:00:01+10:00 http://pharmadispatch.com/news/sanofi-announces-new-global-structure 2015-07-17T16:00:01+10:00 http://pharmadispatch.com/news/ma-hits-back-on-tax 2015-07-17T16:00:01+10:00 http://pharmadispatch.com/news/xenophon-ma-tax-submission-a-veiled-threat 2015-07-20T16:00:01+10:00 http://pharmadispatch.com/news/prescribing-restrictions-could-be-too-tough-says-dusc 2015-07-20T16:00:01+10:00 http://pharmadispatch.com/news/australian-health-spending-low-but-outcomes-good 2015-07-20T16:00:01+10:00 http://pharmadispatch.com/news/could-therapeutic-groups-be-on-the-way-back 2015-07-20T16:00:01+10:00 http://pharmadispatch.com/news/pbs-listing-for-roches-gazyva 2015-07-20T16:00:01+10:00 http://pharmadispatch.com/news/price-disclosure-change-hits-life-cycle-extensions 2015-07-21T16:00:01+10:00 http://pharmadispatch.com/news/biosimilars-forum-moving-closer 2015-07-21T16:00:01+10:00 http://pharmadispatch.com/news/bms-halts-another-opdivo-trial 2015-07-21T15:21:01+10:00 http://pharmadispatch.com/news/three-industry-bodies-to-nominate-pbac-member 2015-07-22T16:00:01+10:00 http://pharmadispatch.com/news/chf-look-beyond-tax-for-health-funding 2015-07-22T16:00:01+10:00 http://pharmadispatch.com/news/sandoz-the-highlight-for-novartis 2015-07-22T17:00:01+10:00 http://pharmadispatch.com/news/groups-joins-choosing-wisely-australia 2015-07-22T16:28:01+10:00 http://pharmadispatch.com/news/australian-generic-prices-match-uk 2015-07-23T16:00:01+10:00 http://pharmadispatch.com/news/self-care-the-focus-of-asmi-conference-1 2015-07-23T16:00:01+10:00 http://pharmadispatch.com/news/guilds-new-corporate-plan 2015-07-23T16:00:01+10:00 http://pharmadispatch.com/news/first-meeting-of-biosimilars-companies 2015-07-23T16:00:01+10:00 http://pharmadispatch.com/news/new-therapies-offer-hope-in-alzheimers-disease 2015-07-23T16:00:01+10:00 http://pharmadispatch.com/news/crotty-leaves-a-stronger-more-focussed-organisation 2015-07-24T00:20:01+10:00 http://pharmadispatch.com/news/time-to-mend-political-fences 2015-07-27T16:00:01+10:00 http://pharmadispatch.com/news/new-pbs-adviser-for-sussan-ley 2015-07-24T16:00:01+10:00 http://pharmadispatch.com/news/bms-and-pfizer-welcome-expanded-eliquis-listing 2015-07-24T16:00:01+10:00 http://pharmadispatch.com/news/ma-loses-a-member 2015-08-20T16:00:01+10:00 http://pharmadispatch.com/news/dahmen-steps-down-as-mpa-chair 2015-07-24T14:32:01+10:00 http://pharmadispatch.com/news/opdivo-boosts-bms 2015-07-24T15:37:01+10:00 http://pharmadispatch.com/news/lilly-posts-better-than-expected-result 2015-07-24T15:50:01+10:00 http://pharmadispatch.com/news/minister-confirms-wider-lucentis-listing 2015-07-24T16:03:01+10:00 http://pharmadispatch.com/news/mark-crotty 2015-07-27T16:00:01+10:00 http://pharmadispatch.com/news/calm-before-the-storm-1996-to-1998 2015-07-27T16:00:01+10:00 http://pharmadispatch.com/news/fresenius-kabi-sells-oncology-compounding-business 2015-07-27T16:00:01+10:00 http://pharmadispatch.com/news/pbac-patients-must-understand-managed-entry-risks 2015-07-27T16:00:01+10:00 http://pharmadispatch.com/news/company-results-celgene-and-shire 2015-07-27T16:00:01+10:00 http://pharmadispatch.com/news/ma-launches-new-facts-book 2015-07-27T16:00:01+10:00 http://pharmadispatch.com/news/hepatitis-groups-want-action 2015-07-28T16:00:01+10:00 http://pharmadispatch.com/news/apa-a-very-special-day 2015-07-28T16:00:01+10:00 http://pharmadispatch.com/news/the-slow-motion-train-wreck-1999-to-2000 2015-07-28T16:00:01+10:00 http://pharmadispatch.com/news/teva-acquires-allergan-global-generics-business-for-us405bn 2015-07-28T16:00:01+10:00 http://pharmadispatch.com/news/company-results-abbvie-biogen-and-valeant 2015-07-28T16:00:01+10:00 http://pharmadispatch.com/news/a-bear-with-a-sore-head-2000-to-2001 2015-07-29T16:00:01+10:00 http://pharmadispatch.com/news/new-leadership-coming-for-bms-australia 2015-07-29T16:00:01+10:00 http://pharmadispatch.com/news/csl-competitive-advanced-manufacturing-within-reach-for-australi 2015-07-30T04:00:01+10:00 http://pharmadispatch.com/news/teva-drops-pursuit-of-mylan 2015-07-29T16:00:01+10:00 http://pharmadispatch.com/news/company-results-pfizer-and-merck-co 2015-07-29T16:00:01+10:00 http://pharmadispatch.com/news/australia-not-moving-on-tpp 2015-07-30T16:00:01+10:00 http://pharmadispatch.com/news/name-change-for-gmia 2015-07-30T16:00:01+10:00 http://pharmadispatch.com/news/msd-more-needs-to-be-done-on-hep-c 2015-07-30T16:00:01+10:00 http://pharmadispatch.com/news/lessons 2015-07-30T16:00:01+10:00 http://pharmadispatch.com/news/company-results-gilead-1 2015-07-30T16:00:01+10:00 http://pharmadispatch.com/news/patients-welcome-new-myeloma-therapy 2015-07-31T16:00:01+10:00 http://pharmadispatch.com/news/janssen-registers-new-infliximab 2015-07-31T16:00:01+10:00 http://pharmadispatch.com/news/viiv-the-highlight-for-gsk 2015-07-31T16:00:01+10:00 http://pharmadispatch.com/news/genzyme-and-lower-costs-boost-sanofi 2015-07-31T16:00:01+10:00 http://pharmadispatch.com/news/az-result-better-than-expected 2015-07-31T16:00:01+10:00 http://pharmadispatch.com/news/amgen-raises-guidance 2015-07-31T16:12:01+10:00 http://pharmadispatch.com/news/regulated-into-irrelevance 2015-08-03T13:00:01+10:00 http://pharmadispatch.com/news/australian-must-share-tpp-blame 2015-08-03T16:00:01+10:00 http://pharmadispatch.com/news/chf-survey-backs-wider-role-for-pharmacy 2015-08-03T16:00:01+10:00 http://pharmadispatch.com/news/soliris-boosts-alexion 2015-08-03T16:00:01+10:00 http://pharmadispatch.com/news/sandoz-boss-to-lead-gbma 2015-08-03T16:00:01+10:00 http://pharmadispatch.com/news/in-contrast-nz-stands-firm-on-pharmac-changes 2015-08-04T16:00:01+10:00 http://pharmadispatch.com/news/robb-shifts-blame-to-us 2015-08-04T16:00:01+10:00 http://pharmadispatch.com/news/csl-australia-needs-to-get-everything-right-on-investment 2015-08-04T16:00:01+10:00 http://pharmadispatch.com/news/trade 2015-08-04T16:00:01+10:00 http://pharmadispatch.com/news/department-rejects-anao-pharmacy-claims 2015-08-05T16:00:01+10:00 http://pharmadispatch.com/news/novartis-oncologys-christoph-lorez 2015-08-05T16:00:01+10:00 http://pharmadispatch.com/news/department-drops-venezuela 2015-08-05T16:00:01+10:00 http://pharmadispatch.com/news/still-waiting-for-senate-cancer-drugs-report 2015-08-05T16:00:01+10:00 http://pharmadispatch.com/news/eu-approves-pfizers-acquisition-of-hospira 2015-08-05T15:47:01+10:00 http://pharmadispatch.com/news/guild-backs-better-approach-to-chronic-conditions 2015-08-05T16:12:01+10:00 http://pharmadispatch.com/news/another-deal-for-pharmaxis 2015-08-06T16:00:01+10:00 http://pharmadispatch.com/news/what-is-a-biologic 2015-08-06T16:00:01+10:00 http://pharmadispatch.com/news/quilty-peoples-lives-are-depending-upon-it 2015-08-06T16:00:01+10:00 http://pharmadispatch.com/news/shire-makes-us30bn-for-baxalta 2015-08-06T16:01:01+10:00 http://pharmadispatch.com/news/bi-reports-slight-growth 2015-08-06T16:19:01+10:00 http://pharmadispatch.com/news/stop-dropping-the-ball-on-prostate-health 2015-08-07T16:00:01+10:00 http://pharmadispatch.com/news/new-look-maestro 2015-08-07T16:00:01+10:00 http://pharmadispatch.com/news/pharma-exports-plummet 2015-08-07T16:00:01+10:00 http://pharmadispatch.com/news/new-job-for-ex-gmia-ceo 2015-08-07T16:00:01+10:00 http://pharmadispatch.com/news/new-look-maestro-1 2015-08-07T16:00:01+10:00 http://pharmadispatch.com/news/andre-musto-collaboration-is-key 2015-08-10T16:00:01+10:00 http://pharmadispatch.com/news/when-the-marines-landed-in-australia 2015-08-10T16:01:01+10:00 http://pharmadispatch.com/news/market-recovers-in-july 2015-08-10T16:00:01+10:00 http://pharmadispatch.com/news/pfizer-sells-north-ryde-site 2015-08-10T16:00:01+10:00 http://pharmadispatch.com/news/capped-pbs-the-biggest-strategic-threat 2015-08-10T16:00:01+10:00 http://pharmadispatch.com/news/company-results-allergan-mylan-and-merck-serono 2015-08-10T16:00:01+10:00 http://pharmadispatch.com/news/good-buy-comes-at-a-price-for-sigma 2015-08-11T16:00:01+10:00 http://pharmadispatch.com/news/mixed-story-on-manufacturing 2015-08-11T16:00:01+10:00 http://pharmadispatch.com/news/cancer-screening-pioneer-appointed-first-emeritus-scientist-by-c 2015-08-11T16:00:01+10:00 http://pharmadispatch.com/news/the-launch-of-jobsdispatch 2015-08-11T16:00:01+10:00 http://pharmadispatch.com/news/az-announced-another-cancer-collaboration-1 2015-08-11T16:00:01+10:00 http://pharmadispatch.com/news/inquiry-backs-mrff 2015-08-11T00:30:01+10:00 http://pharmadispatch.com/news/us-decision-highlights-challenge-for-pcsk9-companies 2015-08-12T16:00:01+10:00 http://pharmadispatch.com/news/stay-strong-gbma-tells-andrew-robb 2015-08-12T16:00:01+10:00 http://pharmadispatch.com/news/sussan-ley-action-required-on-chronic-disease 2015-08-12T16:00:01+10:00 http://pharmadispatch.com/news/victoria-wants-industry 2015-08-12T16:00:01+10:00 http://pharmadispatch.com/news/visualising-the-acid-pocket 2015-08-12T16:00:01+10:00 http://pharmadispatch.com/news/gps-demand-change-on-obesity 2015-08-12T16:00:01+10:00 http://pharmadispatch.com/news/immunoglobulin-sales-boost-csl 2015-08-13T16:00:01+10:00 http://pharmadispatch.com/news/robb-doubts-industry-trust 2015-08-13T16:00:01+10:00 http://pharmadispatch.com/news/parliament-backs-20bn-mrff 2015-08-13T16:00:01+10:00 http://pharmadispatch.com/news/still-no-pbs-for-brintellix 2015-08-13T16:00:01+10:00 http://pharmadispatch.com/news/accc-backs-pfizers-hospira-acquistion 2015-08-13T05:35:01+10:00 http://pharmadispatch.com/news/tga-approves-first-biosimilar-infliximab 2015-08-14T16:00:01+10:00 http://pharmadispatch.com/news/psa15-the-most-successful-to-date 2015-08-14T16:00:01+10:00 http://pharmadispatch.com/news/industry-appointment-far-from-certain 2015-08-14T16:00:01+10:00 http://pharmadispatch.com/news/pfizer-welcomes-accc-approval 2015-08-14T16:00:01+10:00 http://pharmadispatch.com/news/priceline-pharmacy-backing-womens-sport 2015-08-14T16:00:01+10:00 http://pharmadispatch.com/news/long-list-of-september-changes 2015-08-17T16:00:01+10:00 http://pharmadispatch.com/news/janssen-confirms-hep-c-removal 2015-08-17T16:00:01+10:00 http://pharmadispatch.com/news/pharma-companies-recognised-in-hr-awards 2015-08-17T16:00:01+10:00 http://pharmadispatch.com/news/tax-inquiry-set-to-deliver-first-report 2015-08-17T16:00:01+10:00 http://pharmadispatch.com/news/pfizer-stacking-up-approvals 2015-08-17T16:00:01+10:00 http://pharmadispatch.com/news/2016-annus-horribilis-for-pharmaceutical-sector 2015-08-18T16:00:01+10:00 http://pharmadispatch.com/news/shire-could-up-bid-for-baxalta 2015-08-18T16:00:01+10:00 http://pharmadispatch.com/news/department-consults-on-pbac-guidelines 2015-08-18T16:00:01+10:00 http://pharmadispatch.com/news/real-story-is-behind-the-medicare-numbers 2015-08-18T16:00:01+10:00 http://pharmadispatch.com/news/innovation-at-abbvie 2015-08-18T16:00:01+10:00 http://pharmadispatch.com/news/will-pharmacists-have-to-pay-delivery-charges 2015-08-19T16:00:01+10:00 http://pharmadispatch.com/news/petition-wants-action-on-drug-access 2015-08-19T16:00:01+10:00 http://pharmadispatch.com/news/first-tax-report-passes-on-pharma 2015-08-19T16:00:01+10:00 http://pharmadispatch.com/news/political-leaders-speak-in-support-of-innovation 2015-08-19T16:00:01+10:00 http://pharmadispatch.com/news/billion-dollar-crunch 2015-08-20T16:00:01+10:00 http://pharmadispatch.com/news/f1-cut-applied-to-molecules 2015-08-20T16:00:01+10:00 http://pharmadispatch.com/news/disconnect-on-corporate-tax 2015-08-20T16:00:01+10:00 http://pharmadispatch.com/news/another-ip-review 2015-08-20T16:00:01+10:00 http://pharmadispatch.com/news/tga-approves-biosim-inflximab-with-all-indications 2015-08-20T20:01:01+10:00 http://pharmadispatch.com/news/charity-award-for-ms-research-australia 2015-08-21T16:00:01+10:00 http://pharmadispatch.com/news/focus-on-pbac-infliximab-outcome 2015-08-21T16:00:01+10:00 http://pharmadispatch.com/news/patient-access-hep-c-therapy-from-india 2015-08-21T16:00:01+10:00 http://pharmadispatch.com/news/pbac-a-flags-infliximab 2015-08-22T02:00:01+10:00 http://pharmadispatch.com/news/pricing-disputes-inevitable 2015-08-24T16:00:01+10:00 http://pharmadispatch.com/news/groups-line-up-against-a-flag 2015-08-24T16:00:01+10:00 http://pharmadispatch.com/news/a-flag-not-so-simple 2015-08-24T16:00:01+10:00 http://pharmadispatch.com/news/hepatitis-australia-time-for-action-on-new-therapies 2015-08-24T16:00:01+10:00 http://pharmadispatch.com/news/july-pbac-outcome-highlights 2015-08-24T16:00:01+10:00 http://pharmadispatch.com/news/maestro-breaks-down-july-pbac 2015-08-24T16:00:01+10:00 http://pharmadispatch.com/news/patients-delaying-treatment 2015-08-25T16:00:01+10:00 http://pharmadispatch.com/news/patients-not-happy 2015-08-25T16:00:01+10:00 http://pharmadispatch.com/news/avoiding-weight-loss-discussions 2015-08-25T16:00:01+10:00 http://pharmadispatch.com/news/murby-work-against-pbac-recommendation 2015-08-25T16:00:01+10:00 http://pharmadispatch.com/news/us-approved-pfizer-acquistion 2015-08-25T16:00:01+10:00 http://pharmadispatch.com/news/new-guide-on-industry-hco-collaborations-1 2015-08-25T16:00:01+10:00 http://pharmadispatch.com/news/ma-board-election 2015-08-26T16:00:01+10:00 http://pharmadispatch.com/news/blackmores-reports-record-result 2015-08-26T16:00:01+10:00 http://pharmadispatch.com/news/submission-deadline-extended 2015-08-26T16:00:01+10:00 http://pharmadispatch.com/news/mp-adult-vaccination-rate-too-low 2015-08-26T16:00:01+10:00 http://pharmadispatch.com/news/strong-growth-for-ebos 2015-08-26T16:00:01+10:00 http://pharmadispatch.com/news/innovate-to-grow 2015-08-27T16:00:01+10:00 http://pharmadispatch.com/news/bennelong-forum-hosts-deputy-pm 2015-08-27T16:00:01+10:00 http://pharmadispatch.com/news/michael-wonder-breaks-down-the-november-pbac-agenda-2 2015-08-27T16:00:01+10:00 http://pharmadispatch.com/news/selected-highlights-from-november-pbac 2015-08-27T16:00:01+10:00 http://pharmadispatch.com/news/potential-upside-for-ebos 2015-08-27T16:00:01+10:00 http://pharmadispatch.com/news/jj-backs-new-innovation-prize 2015-08-28T16:00:01+10:00 http://pharmadispatch.com/news/tens-of-thousands-delaying-treatment 2015-08-28T16:00:01+10:00 http://pharmadispatch.com/news/bayers-nelson-ambrogio 2015-08-28T16:00:01+10:00 http://pharmadispatch.com/news/deal-to-close-next-week 2015-08-28T16:00:01+10:00 http://pharmadispatch.com/news/new-fda-biosimilar-naming-convention 2015-08-28T16:00:01+10:00 http://pharmadispatch.com/news/time-for-change-say-industry-leaders 2015-08-31T16:00:01+10:00 http://pharmadispatch.com/news/new-pbs-option-for-psoriasis-patients 2015-09-01T16:00:01+10:00 http://pharmadispatch.com/news/australia-in-front-on-keytruda 2015-09-01T16:00:01+10:00 http://pharmadispatch.com/news/16-nominate-for-ma-board 2015-09-01T16:00:01+10:00 http://pharmadispatch.com/news/bms-collaborates-with-brisbane-based-research-institute 2015-09-01T16:00:01+10:00 http://pharmadispatch.com/news/msd-says-thank-you 2015-09-01T16:00:01+10:00 http://pharmadispatch.com/news/chf-backs-biosimilar-a-flagging 2015-09-01T16:00:01+10:00 http://pharmadispatch.com/news/sun-pharma-completes-acquisition-of-gsk-opiates-business 2015-09-02T16:00:01+10:00 http://pharmadispatch.com/news/once-daily-vyvanse-pbs-listed 2015-09-02T16:00:01+10:00 http://pharmadispatch.com/news/more-recognition-for-abbvie 2015-09-02T16:00:01+10:00 http://pharmadispatch.com/news/chnages-for-ibuprofen 2015-09-02T16:00:01+10:00 http://pharmadispatch.com/news/positive-results-for-new-osteoporosis-therapy 2015-09-03T16:00:01+10:00 http://pharmadispatch.com/news/novartis-and-amgen-enter-neuroscience-collaboration 2015-09-03T16:00:01+10:00 http://pharmadispatch.com/news/amwg-set-to-resume 2015-09-03T16:00:01+10:00 http://pharmadispatch.com/news/tga-advisory-group-said-no-to-biosimilar-a-flag 2015-09-03T16:00:01+10:00 http://pharmadispatch.com/news/australia-putting-tpp-at-risk 2015-09-04T16:00:01+10:00 http://pharmadispatch.com/news/companies-respond-to-senate-tax-questions-1 2015-09-04T16:00:01+10:00 http://pharmadispatch.com/news/pfizer-completes-hospira-acquisition 2015-09-04T16:00:01+10:00 http://pharmadispatch.com/news/novartis-launches-first-biosimilar-in-the-us 2015-09-04T16:00:01+10:00 http://pharmadispatch.com/news/wider-implications-of-pfizer-acquisition 2015-09-07T16:00:01+10:00 http://pharmadispatch.com/news/biosimilar-policy-set-to-be-tested 2015-09-07T16:00:01+10:00 http://pharmadispatch.com/news/patients-we-need-access 2015-09-07T16:00:01+10:00 http://pharmadispatch.com/news/international-workshop-set-to-discuss-access 2015-09-07T16:00:01+10:00 http://pharmadispatch.com/news/review-targets-opiods-and-antibiotics 2015-09-07T16:00:01+10:00 http://pharmadispatch.com/news/az-inks-deal-with-australian-biotech 2015-09-08T16:00:01+10:00 http://pharmadispatch.com/news/new-study-confirms-poor-adherence 2015-09-08T16:00:01+10:00 http://pharmadispatch.com/news/csl-standing-firm-on-pay-offer 2015-09-08T16:00:01+10:00 http://pharmadispatch.com/news/cancer-groups-want-action-from-inquiry 2015-09-08T16:00:01+10:00 http://pharmadispatch.com/news/apotex-partners-with-medadvisor 2015-09-08T16:00:01+10:00 http://pharmadispatch.com/news/5-billion-hole-in-pbs-budget 2015-09-09T16:00:01+10:00 http://pharmadispatch.com/news/another-delay 2015-09-09T16:00:01+10:00 http://pharmadispatch.com/news/negotiating-prices-a-major-factor-in-access-delays 2015-09-09T16:00:01+10:00 http://pharmadispatch.com/news/mylan-goes-to-perrigo-shareholders 2015-09-09T16:00:01+10:00 http://pharmadispatch.com/news/ma-looking-forward-but-delivers-brutal-assessment-of-its-negotia 2015-09-10T16:00:01+10:00 http://pharmadispatch.com/news/market-returns-to-growth 2015-09-10T16:00:01+10:00 http://pharmadispatch.com/news/msd-announces-itself-with-biosimilar-enbrel 2015-09-10T16:00:01+10:00 http://pharmadispatch.com/news/pfizer-sticks-with-research-based-associations 2015-09-11T16:00:01+10:00 http://pharmadispatch.com/news/like-comparing-a-car-to-an-a380-jet 2015-09-11T16:00:01+10:00 http://pharmadispatch.com/news/better-than-expected-result-for-sigma-on-non-pbs-revenue 2015-09-11T16:00:01+10:00 http://pharmadispatch.com/news/australian-children-with-crohns-disease-given-access-to-at-home- 2015-09-11T16:00:01+10:00 http://pharmadispatch.com/news/tillack-fair-pricing-and-uptake-drivers-the-key 2015-09-11T16:00:01+10:00 http://pharmadispatch.com/news/leading-drug-development-provider-looking-at-australian-expansio 2015-09-11T20:05:01+10:00 http://pharmadispatch.com/news/work-a-thing-you-do-not-a-place-you-need-to-be 2015-09-14T16:00:01+10:00 http://pharmadispatch.com/news/october-pbs-changes 2015-09-14T16:00:01+10:00 http://pharmadispatch.com/news/patients-progressing-to-severe-disease-as-they-wait-for-access 2015-09-14T16:00:01+10:00 http://pharmadispatch.com/news/cancer-report-tomorrow 2015-09-14T16:00:01+10:00 http://pharmadispatch.com/news/prescribing-relaxed-under-red-tape-review 2015-09-14T16:00:01+10:00 http://pharmadispatch.com/news/department-scraps-a-flag-concept 2015-09-15T16:00:01+10:00 http://pharmadispatch.com/news/gsk-goes-to-court 2015-09-15T16:00:01+10:00 http://pharmadispatch.com/news/generational-change-coming 2015-09-15T16:00:01+10:00 http://pharmadispatch.com/news/a-busy-start-to-the-week 2015-09-15T16:00:01+10:00 http://pharmadispatch.com/news/are-things-back-to-normal 2015-09-16T16:00:01+10:00 http://pharmadispatch.com/news/robb-wants-to-stay-in-trade 2015-09-16T16:00:01+10:00 http://pharmadispatch.com/news/mundipharma-signs-distribution-agreement-with-melbourne-based-co 2015-09-16T16:00:01+10:00 http://pharmadispatch.com/news/minister-responds-to-sensipar-petition 2015-09-16T16:00:01+10:00 http://pharmadispatch.com/news/strangely-aligned-to-its-purpose 2015-09-16T16:00:01+10:00 http://pharmadispatch.com/news/pharma-impacted-corporate-tax-changes 2015-09-17T16:00:01+10:00 http://pharmadispatch.com/news/minister-wants-to-stay 2015-09-17T16:00:01+10:00 http://pharmadispatch.com/news/dont-forget-process-ma-tells-guideline-review 2015-09-17T16:00:01+10:00 http://pharmadispatch.com/news/mylan-opens-hostile-bid-for-perrigo 2015-09-17T16:00:01+10:00 http://pharmadispatch.com/news/b-flags-a-historial-concept 2015-09-17T16:00:01+10:00 http://pharmadispatch.com/news/dismay-over-rule-of-rescue 2015-09-18T16:00:01+10:00 http://pharmadispatch.com/news/consumer-survey-backs-pharmacy 2015-09-18T16:00:01+10:00 http://pharmadispatch.com/news/senate-recommends-comprehensive-review-of-pbac-1 2015-09-17T16:00:01+10:00 http://pharmadispatch.com/news/senate-cancer-report-the-recommendations 2015-09-18T16:00:01+10:00 http://pharmadispatch.com/news/the-commitees-view-key-excerpts-of-the-report 2015-09-18T16:00:01+10:00 http://pharmadispatch.com/news/psa-wants-consensus-on-biosimilars 2015-09-18T16:00:01+10:00 http://pharmadispatch.com/news/stakeholders-welcome-senate-cancer-report 2015-09-18T16:00:01+10:00 http://pharmadispatch.com/news/report-signals-the-real-start 2015-09-18T16:00:01+10:00 http://pharmadispatch.com/news/jardiance-shows-reduction-in-cv-deaths 2015-09-18T16:00:01+10:00 http://pharmadispatch.com/news/dont-underestimate-this-outcome 2015-09-21T16:00:01+10:00 http://pharmadispatch.com/news/more-stakeholder-responses-to-cancer-report 2015-09-21T16:00:01+10:00 http://pharmadispatch.com/news/make-or-break-talks-for-tpp 2015-09-21T16:00:01+10:00 http://pharmadispatch.com/news/malcolm-turnbull-announces-new-ministry 2015-09-21T01:41:01+10:00 http://pharmadispatch.com/news/who-is-ken-wyatt 2015-09-21T16:00:01+10:00 http://pharmadispatch.com/news/turnbull-we-need-to-focus-on-translation 2015-09-21T16:00:01+10:00 http://pharmadispatch.com/news/pharmaceutical-spending-fell-in-2014-15 2015-09-21T19:49:01+10:00 http://pharmadispatch.com/news/where-will-the-money-come-from 2015-09-22T16:00:01+10:00 http://pharmadispatch.com/news/the-added-significance-of-ken-wyatts-appointment 2015-09-22T16:00:01+10:00 http://pharmadispatch.com/news/sector-welcomes-turnbulls-health-team 2015-09-22T16:00:01+10:00 http://pharmadispatch.com/news/bi-confirms-new-inhaler-technology-for-pbs 2015-09-22T16:00:01+10:00 http://pharmadispatch.com/news/industry-pbac-nominations-move-closer 2015-09-22T16:00:01+10:00 http://pharmadispatch.com/news/system-starting-to-show-wear-and-tear 2015-09-23T16:00:01+10:00 http://pharmadispatch.com/news/pharmaxis-announces-positive-phase-1-results-for-bi-partnership- 2015-09-23T16:00:01+10:00 http://pharmadispatch.com/news/cannings-relationship-needs-a-circuit-breaker-1 2015-09-23T16:00:01+10:00 http://pharmadispatch.com/news/another-patent-win-for-lundbeck 2015-09-23T16:00:01+10:00 http://pharmadispatch.com/news/link-acquired-by-uk-based-clinigen-1 2015-09-23T16:00:01+10:00 http://pharmadispatch.com/news/hourigan-encouraged-by-turnbull 2015-09-24T16:00:01+10:00 http://pharmadispatch.com/news/infliximab-pi-shows-tga-change 2015-09-24T16:00:01+10:00 http://pharmadispatch.com/news/industry-peddling-propaganda-says-minister 2015-09-24T16:00:01+10:00 http://pharmadispatch.com/news/report-did-not-warrant-that-response 2015-09-24T16:00:01+10:00 http://pharmadispatch.com/news/positive-results-for-avastin-biosimilar 2015-09-24T16:00:01+10:00 http://pharmadispatch.com/news/bms-confirms-tga-registration-for-new-hiv-combo 2015-09-25T16:00:01+10:00 http://pharmadispatch.com/news/political-debate-misses-complexity 2015-09-25T16:00:01+10:00 http://pharmadispatch.com/news/no-rest-for-crotty 2015-09-25T16:00:01+10:00 http://pharmadispatch.com/news/labor-mocks-innovation-claims 2015-09-25T16:00:01+10:00 http://pharmadispatch.com/news/another-report-confirms-falling-pbs-spend 2015-09-25T16:00:01+10:00 http://pharmadispatch.com/news/trade-talks-nearing-the-end 2015-09-28T16:00:01+10:00 http://pharmadispatch.com/news/political-debate-misses-complexity-part-2 2015-09-28T16:00:01+10:00 http://pharmadispatch.com/news/medicare-review-could-impact-pbs 2015-09-28T16:00:01+10:00 http://pharmadispatch.com/news/policy-stability-essential-says-pharmaxis-ceo 2015-09-28T16:00:01+10:00 http://pharmadispatch.com/news/global-recognition-of-ground-breaking-changes 2015-09-28T16:00:01+10:00 http://pharmadispatch.com/news/nsw-govt-scraps-co-pays-for-s100-medicines 2015-09-29T16:00:01+10:00 http://pharmadispatch.com/news/pushing-timelines-in-guidelines-review 2015-09-29T16:00:01+10:00 http://pharmadispatch.com/news/positive-trial-results-for-afinitor 2015-09-29T16:00:01+10:00 http://pharmadispatch.com/news/second-opinions-could-help-address-waste 2015-09-29T16:00:01+10:00 http://pharmadispatch.com/news/new-tga-biosimilar-guideline-close 2015-09-29T16:00:01+10:00 http://pharmadispatch.com/news/mcdonald-we-need-a-wider-focus 2015-09-30T16:00:01+10:00 http://pharmadispatch.com/news/new-therapies-mean-new-treatment-models 2015-09-30T16:00:01+10:00 http://pharmadispatch.com/news/question-low-value-treatments 2015-09-30T16:00:01+10:00 http://pharmadispatch.com/news/compromise-under-discussion 2015-09-30T16:00:01+10:00 http://pharmadispatch.com/news/changes-inside-department-of-health 2015-10-02T01:58:01+10:00 http://pharmadispatch.com/news/gbma-alarm-over-potential-compromise 2015-10-01T16:00:01+10:00 http://pharmadispatch.com/news/nash-retains-tga 2015-10-01T16:00:01+10:00 http://pharmadispatch.com/news/groups-unite-to-call-for-action-on-hep-c 2015-10-01T16:00:01+10:00 http://pharmadispatch.com/news/abbott-a-loyal-and-true-friend-of-pharmacy-2 2015-10-01T16:00:01+10:00 http://pharmadispatch.com/news/new-code-era-starts-today 2015-10-01T16:00:01+10:00 http://pharmadispatch.com/news/tpp-talks-extended-by-a-day 2015-10-02T16:00:01+10:00 http://pharmadispatch.com/news/rescheduling-codeine-not-the-answer 2015-10-02T16:00:01+10:00 http://pharmadispatch.com/news/pm-pushes-innovation 2015-10-02T16:00:01+10:00 http://pharmadispatch.com/news/mixed-results-on-impact-of-drugs-costs 2015-10-02T16:00:01+10:00 http://pharmadispatch.com/news/gladsden-time-for-a-fresh-start-and-clear-thinking 2015-10-06T17:00:01+11:00 http://pharmadispatch.com/news/countries-agree-historic-tpp 2015-10-06T17:00:01+11:00 http://pharmadispatch.com/news/opposition-builds-to-codeine-schedule-change 2015-10-06T17:00:01+11:00 http://pharmadispatch.com/news/structural-reform-coming 2015-10-06T17:00:01+11:00 http://pharmadispatch.com/news/australia-second-tier-biotech-country 2015-10-06T17:00:01+11:00 http://pharmadispatch.com/news/tppa-is-all-about-perspective 2015-10-07T17:00:01+11:00 http://pharmadispatch.com/news/industry-groups-consider-pbac-candidates 2015-10-07T17:00:01+11:00 http://pharmadispatch.com/news/more-biosimilars-coming 2015-10-07T17:00:01+11:00 http://pharmadispatch.com/news/award-nomination-for-ex-pbs-head 2015-10-07T17:00:01+11:00 http://pharmadispatch.com/news/nobel-prize-for-retired-merck-scientist 2015-10-07T17:00:01+11:00 http://pharmadispatch.com/news/mixed-views-on-tpp-outcome 2015-10-07T17:00:01+11:00 http://pharmadispatch.com/news/high-court-overturns-gene-patents 2015-10-08T17:00:01+11:00 http://pharmadispatch.com/news/biosimilar-implementation-plan-coming 2015-10-08T17:00:01+11:00 http://pharmadispatch.com/news/wonder-compares-australia-and-europe-on-cancer-medicines 2015-10-08T17:00:01+11:00 http://pharmadispatch.com/news/sigmas-hooper-new-npsa-chair 2015-10-08T17:00:01+11:00 http://pharmadispatch.com/news/time-for-urgent-action 2015-10-08T17:00:01+11:00 http://pharmadispatch.com/news/grants-to-support-research-into-macular-disease 2015-10-08T17:00:01+11:00 http://pharmadispatch.com/news/msd-extends-collaboration-with-australian-biotech 2015-10-09T17:00:01+11:00 http://pharmadispatch.com/news/final-day-of-ma-election 2015-10-09T17:00:01+11:00 http://pharmadispatch.com/news/innovation-hackathon 2015-10-09T17:00:01+11:00 http://pharmadispatch.com/news/an-apology-might-be-the-place-to-start 2015-10-09T17:00:01+11:00 http://pharmadispatch.com/news/tpp-requires-market-protection-period-for-biologics 2015-10-10T17:22:01+11:00 http://pharmadispatch.com/news/whats-a-comparable-outcome 2015-10-12T11:00:01+11:00 http://pharmadispatch.com/news/prioritising-patients-will-be-essential 2015-10-12T17:00:01+11:00 http://pharmadispatch.com/news/empowering-patients-with-arthritis 2015-10-12T17:00:01+11:00 http://pharmadispatch.com/news/october-price-cuts-to-hit-market-value 2015-10-12T17:00:01+11:00 http://pharmadispatch.com/news/a-morning-dose-of-health-news-sets-you-up-for-the-day 2015-10-19T17:00:01+11:00 http://pharmadispatch.com/news/tpp-stance-driven-by-political-considerations 2015-10-12T17:00:01+11:00 http://pharmadispatch.com/news/december-listing-for-inflectra 2015-10-14T17:00:01+11:00 http://pharmadispatch.com/news/ma-chair-steps-down 2015-10-12T20:43:01+11:00 http://pharmadispatch.com/news/new-cancer-therapy-headlines-november-listings 2015-10-13T17:00:01+11:00 http://pharmadispatch.com/news/acting-ma-chair-likely 2015-10-13T17:00:01+11:00 http://pharmadispatch.com/news/new-app-to-help-australian-cancer-patients 2015-10-13T17:00:01+11:00 http://pharmadispatch.com/news/australians-skipping-gp-advice-for-hay-fever 2015-10-13T17:00:01+11:00 http://pharmadispatch.com/news/biosimilars-framework 2015-10-13T17:00:01+11:00 http://pharmadispatch.com/news/new-studies-boost-amgens-prolia 2015-10-14T17:00:01+11:00 http://pharmadispatch.com/news/msd-progressing-keytruda-in-lung-cancer 2015-10-14T17:00:01+11:00 http://pharmadispatch.com/news/guild-backs-walk4braincancer 2015-10-14T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-partners-with-mcgrath-foundation 2015-10-15T04:38:01+11:00 http://pharmadispatch.com/news/labor-has-7-in-health-and-sport-portfolio80 2015-10-14T17:00:01+11:00 http://pharmadispatch.com/news/currency-hits-jj-result 2015-10-14T17:00:01+11:00 http://pharmadispatch.com/news/risk-share-revenue-soars 2015-10-15T17:00:01+11:00 http://pharmadispatch.com/news/savings-hit-2-billion-as-pbs-falls 2015-10-15T17:00:01+11:00 http://pharmadispatch.com/news/the-word-sustainability 2015-10-16T05:00:01+11:00 http://pharmadispatch.com/news/new-ma-board-taking-shape 2015-10-15T17:00:01+11:00 http://pharmadispatch.com/news/csl-announces-1-billion-share-buyback 2015-10-16T17:00:01+11:00 http://pharmadispatch.com/news/ma-board-sticks-with-existing-members 2015-10-16T17:00:01+11:00 http://pharmadispatch.com/news/ausbiotech-seeks-member-input-on-pbac 2015-10-16T17:00:01+11:00 http://pharmadispatch.com/news/merck-launches-global-rebrand 2015-10-16T17:00:01+11:00 http://pharmadispatch.com/news/codeine-change-would-cost-257-million 2015-10-16T17:00:01+11:00 http://pharmadispatch.com/news/volatlie-market-hits-janssen-jobs 2015-10-19T17:00:01+11:00 http://pharmadispatch.com/news/decision-looms-on-acting-chair 2015-10-19T17:00:01+11:00 http://pharmadispatch.com/news/new-faces-front-estimates 2015-10-19T17:00:01+11:00 http://pharmadispatch.com/news/two-more-post-market-reviews 2015-10-19T03:28:01+11:00 http://pharmadispatch.com/news/medadvisor-ipo-heavily-oversubscribed 2015-10-19T17:00:01+11:00 http://pharmadispatch.com/news/tga-considers-pradaxa-antidote-as-fda-approves 2015-10-20T17:00:01+11:00 http://pharmadispatch.com/news/pm-backs-budget-co-pay-increase-kind-of 2015-10-20T17:00:01+11:00 http://pharmadispatch.com/news/is-the-latest-review-a-risk-for-new-cholesterol-biologics 2015-10-20T17:00:01+11:00 http://pharmadispatch.com/news/petition-backs-ms-listing 2015-10-20T17:00:01+11:00 http://pharmadispatch.com/news/its-not-new-money 2015-10-21T17:00:01+11:00 http://pharmadispatch.com/news/cochlear-urges-government-to-scrap-rd-tax-cap 2015-10-21T17:00:01+11:00 http://pharmadispatch.com/news/more-complaints-but-fines-drop 2015-10-21T17:00:01+11:00 http://pharmadispatch.com/news/bis-wes-cook-steps-into-ma-chair 2015-10-21T17:00:01+11:00 http://pharmadispatch.com/news/valeant-shifts-business-towards-higher-rd-spend 2015-10-21T17:00:01+11:00 http://pharmadispatch.com/news/not-off-the-tableunless-an-offset-is-found 2015-10-22T17:00:01+11:00 http://pharmadispatch.com/news/no-price-agreement-on-hep-c-therapies 2015-10-22T17:00:01+11:00 http://pharmadispatch.com/news/this-could-be-an-opportunity 2015-10-22T17:00:01+11:00 http://pharmadispatch.com/news/opsumit-growth-boosts-actelion 2015-10-22T17:00:01+11:00 http://pharmadispatch.com/news/new-study-backs-b3-derivative-in-new-skin-cancers 2015-10-23T17:00:01+11:00 http://pharmadispatch.com/news/government-rethink-on-rd-tax-cut 2015-10-23T17:00:01+11:00 http://pharmadispatch.com/news/api-retail-push-delivering-results 2015-10-23T17:00:01+11:00 http://pharmadispatch.com/news/guild-proposes-real-time-monitoring-for-codeine 2015-10-23T17:00:01+11:00 http://pharmadispatch.com/news/farmaforce-set-for-asx-debut 2015-10-23T17:00:01+11:00 http://pharmadispatch.com/news/biogen-growth-but-restucture-means-job-cuts 2015-10-23T17:00:01+11:00 http://pharmadispatch.com/news/servier-invests-in-australian-researchers 2015-10-26T17:00:01+11:00 http://pharmadispatch.com/news/lilly-raises-outlook 2015-10-26T17:00:01+11:00 http://pharmadispatch.com/news/roche-progressing-new-therapies 2015-10-26T17:00:01+11:00 http://pharmadispatch.com/news/cook-we-need-constructive-respectful-and-productive-relationship 2015-10-26T17:00:01+11:00 http://pharmadispatch.com/news/perrigo-building-mylan-defence 2015-10-26T17:00:01+11:00 http://pharmadispatch.com/news/gilead-funded-researchers-showcase-results 2015-10-27T17:00:01+11:00 http://pharmadispatch.com/news/ma-still-pushing-as-key-date-approaches 2015-10-27T17:00:01+11:00 http://pharmadispatch.com/news/industry-seeks-to-align-pbac-nominations 2015-10-27T17:00:01+11:00 http://pharmadispatch.com/news/guild-time-for-action-on-services 2015-10-27T17:00:01+11:00 http://pharmadispatch.com/news/forum-to-consider-new-options-for-cancer 2015-10-28T17:00:01+11:00 http://pharmadispatch.com/news/guild-backs-government-on-biosimilars 2015-10-29T05:00:01+11:00 http://pharmadispatch.com/news/cube-extends-management-team-with-new-hire 2015-10-28T17:00:01+11:00 http://pharmadispatch.com/news/new-ceo-for-shpa 2015-10-29T05:00:01+11:00 http://pharmadispatch.com/news/company-results-novartis-pfizer-bms-and-merck 2015-10-28T17:00:01+11:00 http://pharmadispatch.com/news/gbma-welcomes-guilds-biosimilar-statement 2015-10-29T16:11:01+11:00 http://pharmadispatch.com/news/pbs-the-model-for-wider-health-system-reform 2015-10-29T16:24:01+11:00 http://pharmadispatch.com/news/people-discerning-about-dr-google 2015-10-29T16:52:01+11:00 http://pharmadispatch.com/news/guild-welcomes-my-health-record-trials 2015-10-29T17:02:01+11:00 http://pharmadispatch.com/news/8strong-growth-for-gsk-vaccines-and-hiv-therapies0 2015-10-29T17:12:01+11:00 http://pharmadispatch.com/news/a-united-approach-to-address-the-biggest-challenge 2015-10-30T17:00:01+11:00 http://pharmadispatch.com/news/blackmores-soars-on-china-growth 2015-10-30T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-and-allergan-discuss-merger 2015-10-30T17:00:01+11:00 http://pharmadispatch.com/news/amgen-raises-outlook-and-anticipates-launches 2015-10-30T17:00:01+11:00 http://pharmadispatch.com/news/genzyme-the-highlight-for-sanofi 2015-10-30T17:00:01+11:00 http://pharmadispatch.com/news/company-targets-official 2015-11-02T17:00:01+11:00 http://pharmadispatch.com/news/new-pbs-adviser-for-sussan-ley-1 2015-11-02T17:00:01+11:00 http://pharmadispatch.com/news/company-results-baxalta-bayer-novo-nordisk 2015-11-02T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-and-allergan-aiming-for-deal-within-weeks 2015-11-02T17:00:01+11:00 http://pharmadispatch.com/news/ex-guild-president-calls-for-coordinated-approach-to-phi-review 2015-11-02T17:00:01+11:00 http://pharmadispatch.com/news/anger-over-targeting-of-official 2015-11-03T17:00:01+11:00 http://pharmadispatch.com/news/servier-boosting-portfolio 2015-11-03T17:00:01+11:00 http://pharmadispatch.com/news/tolmar-backs-urology-meetings 2015-11-03T17:00:01+11:00 http://pharmadispatch.com/news/increase-and-widen-gst-to-health 2015-11-03T17:00:01+11:00 http://pharmadispatch.com/news/that-list-includes-over-600-generics 2015-11-03T17:00:01+11:00 http://pharmadispatch.com/news/29-medicines-set-to-be-removed-from-pbs 2015-11-04T05:50:01+11:00 http://pharmadispatch.com/news/hospira-did-not-request-infliximab-a-flag 2015-11-03T17:00:01+11:00 http://pharmadispatch.com/news/immune-therapies-reshaping-standard-of-care 2015-11-04T17:00:01+11:00 http://pharmadispatch.com/news/common-ground-on-hcv-listings-but-differences-remain 2015-11-04T17:00:01+11:00 http://pharmadispatch.com/news/pharmac-gives-itself-top-marks 2015-11-04T17:13:01+11:00 http://pharmadispatch.com/news/pbac-remit-includes-innovation-and-industry-sustainability 2015-11-04T17:34:01+11:00 http://pharmadispatch.com/news/an-opportunity-mapped-out-over-coffee 2015-11-05T17:00:01+11:00 http://pharmadispatch.com/news/ebos-acquisition-a-strategic-move-across-pharmaceutical-value-ch 2015-11-05T17:00:01+11:00 http://pharmadispatch.com/news/another-biosimilar-set-for-december-listing-1 2015-11-05T17:00:01+11:00 http://pharmadispatch.com/news/reports-pfizer-approached-gsk-about-merger 2015-11-05T17:00:01+11:00 http://pharmadispatch.com/news/submissions-make-wide-ranging-recommendations 2015-11-05T17:00:01+11:00 http://pharmadispatch.com/news/msds-fiedler-calls-ceo-roundtable-on-gender-equality 2015-11-06T17:00:01+11:00 http://pharmadispatch.com/news/msd-and-baxter-recognised-gender-equality 2015-11-06T17:00:01+11:00 http://pharmadispatch.com/news/job-losses-adding-up 2015-11-06T17:00:01+11:00 http://pharmadispatch.com/news/ma-backs-mandatory-patient-medication-records-3 2015-11-06T17:00:01+11:00 http://pharmadispatch.com/news/the-problem-of-osteoporosis-in-men 2015-11-06T17:00:01+11:00 http://pharmadispatch.com/news/tppa-text-released 2015-11-06T17:00:01+11:00 http://pharmadispatch.com/news/minister-announces-upgrade-for-flu-vax 2015-11-06T17:31:01+11:00 http://pharmadispatch.com/news/single-supplier-for-2016-flu-vax 2015-11-09T17:00:01+11:00 http://pharmadispatch.com/news/global-role-for-genzymes-andre-turenne 2015-11-09T17:00:01+11:00 http://pharmadispatch.com/news/new-sanofi-strategy-could-mean-sales-and-acquisitions 2015-11-09T17:00:01+11:00 http://pharmadispatch.com/news/company-results-astrazeneca-and-celgene 2015-11-10T05:00:01+11:00 http://pharmadispatch.com/news/australia-greedy-on-tppa 2015-11-09T17:00:01+11:00 http://pharmadispatch.com/news/call-for-correction-on-codeine 2015-11-09T17:00:01+11:00 http://pharmadispatch.com/news/gbma-triumph-highlights-risk-for-ma 2015-11-10T17:00:01+11:00 http://pharmadispatch.com/news/government-set-to-reject-review-recommendation 2015-11-10T17:00:01+11:00 http://pharmadispatch.com/news/low-nhmrc-success-rate-a-concern 2015-11-10T17:00:01+11:00 http://pharmadispatch.com/news/australia-wins-from-pharma-tariff-abolition 2015-11-10T17:00:01+11:00 http://pharmadispatch.com/news/senate-report-backs-multinational-tax-changes 2015-11-10T17:00:01+11:00 http://pharmadispatch.com/news/new-biosimilars-keep-coming 2015-11-11T17:00:01+11:00 http://pharmadispatch.com/news/self-care-the-focus-of-todays-asmi-conference 2015-11-11T17:00:01+11:00 http://pharmadispatch.com/news/gbma-locks-up-on-biosimilar-policy 2015-11-11T16:24:01+11:00 http://pharmadispatch.com/news/make-no-mistake-its-8-years-on-data-exclusivity-says-ustr 2015-11-11T17:00:01+11:00 http://pharmadispatch.com/news/otc-companies-should-forget-tv 2015-11-12T17:00:01+11:00 http://pharmadispatch.com/news/we-all-only-get-a-certain-number-of-neurons 2015-11-17T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-accepts-biosimilar-a-flag 2015-11-12T17:00:01+11:00 http://pharmadispatch.com/news/s3-advertising-changes-the-right-choice-for-consumers 2015-11-13T05:00:01+11:00 http://pharmadispatch.com/news/new-dermal-patch-for-the-treatment-of-non-melanoma-skin-cancer 2015-11-12T17:00:01+11:00 http://pharmadispatch.com/news/asmi-appoints-new-board 2015-11-12T17:00:01+11:00 http://pharmadispatch.com/news/asmi-celebrates-at-diamond-awards-annual-dinner 2015-11-12T17:00:01+11:00 http://pharmadispatch.com/news/new-copd-options-and-the-first-generics-for-osteoporosis-therapy 2015-11-13T17:00:01+11:00 http://pharmadispatch.com/news/timely-access-included-in-2016-20-national-diabetes-strategy 2015-11-13T17:00:01+11:00 http://pharmadispatch.com/news/codeine-change-could-add-127-billion-to-mbs 2015-11-13T17:00:01+11:00 http://pharmadispatch.com/news/tax-avoidance-measures-facing-senate-delay 2015-11-13T17:00:01+11:00 http://pharmadispatch.com/news/implementation-plan-for-inflectra 2015-11-13T17:00:01+11:00 http://pharmadispatch.com/news/inefficiency-and-uncertainty-in-current-processes 2015-11-13T17:00:01+11:00 http://pharmadispatch.com/news/dusc-notes-higher-than-expected-use-of-pain-therapy 2015-11-16T17:00:01+11:00 http://pharmadispatch.com/news/further-restrictions-on-benzodiazepine 2015-11-16T17:00:01+11:00 http://pharmadispatch.com/news/ma-single-committee-for-co-dependent-technologies 2015-11-16T17:00:01+11:00 http://pharmadispatch.com/news/from-science-to-market 2015-11-16T17:00:01+11:00 http://pharmadispatch.com/news/supporting-the-heart-of-australia 2015-11-16T17:00:01+11:00 http://pharmadispatch.com/news/nostradata-growth-keeps-falling 2015-11-16T17:00:01+11:00 http://pharmadispatch.com/news/history-is-the-guide-on-biosimilar-policy 2015-11-17T17:00:01+11:00 http://pharmadispatch.com/news/another-acquisition-for-ebos 2015-11-17T17:00:01+11:00 http://pharmadispatch.com/news/are-australians-slowly-getting-it-on-antibiotics 2015-11-17T17:00:01+11:00 http://pharmadispatch.com/news/pbac-challenged-on-infliximab-assumptions 2015-11-18T17:00:01+11:00 http://pharmadispatch.com/news/tga-approves-new-antibiotic-1 2015-11-18T17:00:01+11:00 http://pharmadispatch.com/news/new-chair-of-innovation-australia-1 2015-11-18T17:00:01+11:00 http://pharmadispatch.com/news/self-care-the-sustainable-option 2015-11-18T17:00:01+11:00 http://pharmadispatch.com/news/export-the-pbs-to-china 2015-11-18T17:00:01+11:00 http://pharmadispatch.com/news/ims-and-nostradata-announce-joint-venture 2015-11-19T17:00:01+11:00 http://pharmadispatch.com/news/research-australia-awards-2 2015-11-19T17:00:01+11:00 http://pharmadispatch.com/news/a-factsheet-for-biosimilar-implementation-plan 2015-11-19T17:00:01+11:00 http://pharmadispatch.com/news/policyhack-outcomes-back-ip-and-rd-tax-change 2015-11-20T17:00:01+11:00 http://pharmadispatch.com/news/melbourne-researchers-win-gsk-award-for-research-excellence 2015-11-20T17:00:01+11:00 http://pharmadispatch.com/news/tga-buys-time-on-codeine-scheduling-change 2015-11-20T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-and-allergan-in-final-stages-of-merger-talks 2015-11-20T17:00:01+11:00 http://pharmadispatch.com/news/merger-going-ahead-despite-us-tax-change 2015-11-23T17:00:01+11:00 http://pharmadispatch.com/news/panel-sticks-with-current-s3-restrictions 2015-11-23T17:00:01+11:00 http://pharmadispatch.com/news/give-tga-right-to-refuse-listing 2015-11-23T17:00:01+11:00 http://pharmadispatch.com/news/government-should-create-incentives-for-innovation 2015-11-23T17:00:01+11:00 http://pharmadispatch.com/news/journey-to-the-heart-of-australia 2015-11-23T17:00:01+11:00 http://pharmadispatch.com/news/reviews-missed-the-boat-on-advertising 2015-11-23T15:45:01+11:00 http://pharmadispatch.com/news/lichtenberg-a-rather-striking-result-in-australia 2015-11-24T17:00:01+11:00 http://pharmadispatch.com/news/get-this-right-and-many-problems-might-go-away 2015-11-24T17:00:01+11:00 http://pharmadispatch.com/news/new-study-shows-dire-need-for-access 2015-11-24T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-and-allergan-announce-merger 2015-11-24T17:00:01+11:00 http://pharmadispatch.com/news/rey-highlights-of-the-lichtenberg-study 2015-11-24T17:00:01+11:00 http://pharmadispatch.com/news/csl-subsidiary-launches-first-product-under-new-name-2 2015-11-24T17:00:01+11:00 http://pharmadispatch.com/news/novo-nordisk-the-latest-to-announce-job-cuts 2015-11-25T17:00:01+11:00 http://pharmadispatch.com/news/accc-fines-epharmacy-group 2015-11-25T17:00:01+11:00 http://pharmadispatch.com/news/for-benefit-medicines-launches-with-breast-cancer-therapies 2015-11-25T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-allergan-merger-could-face-new-regulatory-hurdles 2015-11-25T17:00:01+11:00 http://pharmadispatch.com/news/economic-benefit-of-vitamin-b3-supplementation 2015-11-25T17:00:01+11:00 http://pharmadispatch.com/news/pharmacy-review-panel-a-mixed-bag 2015-11-25T17:00:01+11:00 http://pharmadispatch.com/news/innovation-about-more-than-apps 2015-11-26T17:00:01+11:00 http://pharmadispatch.com/news/novartis-australia-brings-patients-closer-to-clinical-trial-desi 2015-11-26T17:00:01+11:00 http://pharmadispatch.com/news/review-sets-pharmacy-battlelines 2015-11-26T17:00:01+11:00 http://pharmadispatch.com/news/lucy-turnbull-sticks-with-prima-biomed 2015-11-26T17:00:01+11:00 http://pharmadispatch.com/news/us-unhappy-but-pfizer-allergan-a-big-tax-win-for-ireland 2015-11-26T17:00:01+11:00 http://pharmadispatch.com/news/new-second-line-treatment-for-metastatic-renal-cell-carcinoma 2015-11-27T17:00:01+11:00 http://pharmadispatch.com/news/victoria-expands-the-role-of-community-pharmacy 2015-11-27T17:00:01+11:00 http://pharmadispatch.com/news/pbs-drug-use-varies-across-australia1 2015-11-27T17:00:01+11:00 http://pharmadispatch.com/news/stakeholder-support-for-mental-health-reforms 2015-11-27T17:00:01+11:00 http://pharmadispatch.com/news/department-releases-new-stakeholder-engagement-framework 2015-11-27T17:00:01+11:00 http://pharmadispatch.com/news/amgen-submits-biosimilar-humira-in-the-us 2015-11-30T17:00:01+11:00 http://pharmadispatch.com/news/december-almost-here-but-the-year-far-from-over 2015-11-30T17:00:01+11:00 http://pharmadispatch.com/news/sanofi-moves-closer-to-sale-of-animal-health-unit 2015-11-30T17:00:01+11:00 http://pharmadispatch.com/news/msd-launches-website-resource-for-hcps 2015-11-30T17:00:01+11:00 http://pharmadispatch.com/news/shire-prepares-another-bid-for-baxalta 2015-11-30T17:00:01+11:00 http://pharmadispatch.com/news/innovation-prime-minister-yes-please 2015-12-01T17:00:01+11:00 http://pharmadispatch.com/news/companies-back-hepatitis-australia 2015-12-01T17:00:01+11:00 http://pharmadispatch.com/news/ausbiotech-extend-data-exclusivity-period 2015-12-01T17:00:01+11:00 http://pharmadispatch.com/news/another-2bn-for-mrff 2015-12-01T17:00:01+11:00 http://pharmadispatch.com/news/department-distributes-biosimilar-fact-sheet 2015-12-01T17:00:01+11:00 http://pharmadispatch.com/news/the-infliximab-fact-sheet-and-the-facts 2015-12-02T17:00:01+11:00 http://pharmadispatch.com/news/change-a-constant-in-department-of-health 2015-12-03T17:00:01+11:00 http://pharmadispatch.com/news/biosimilar-focus-turns-to-prescribing-and-uptake 2015-12-02T17:00:01+11:00 http://pharmadispatch.com/news/strong-first-day-for-medadvisor 2015-12-02T17:00:01+11:00 http://pharmadispatch.com/news/minister-blames-a-company-over-access-again 2015-12-02T17:00:01+11:00 http://pharmadispatch.com/news/gilead-confirms-truvada-tga-submission 2015-12-03T17:00:01+11:00 http://pharmadispatch.com/news/incarda-therapeutics-announces-australian-operation 2015-12-03T17:00:01+11:00 http://pharmadispatch.com/news/australia-set-to-follow-europe-on-biosimilar-enbrel 2015-12-03T17:00:01+11:00 http://pharmadispatch.com/news/new-report-backs-impact-of-rd-tax-incentive 2015-12-04T17:00:01+11:00 http://pharmadispatch.com/news/higher-treatment-rates-drive-increase-in-hospitalisations 2015-12-04T17:00:01+11:00 http://pharmadispatch.com/news/tga-updates-champix-pi 2015-12-04T17:00:01+11:00 http://pharmadispatch.com/news/senate-backs-corporate-tax-changes 2015-12-04T17:00:01+11:00 http://pharmadispatch.com/news/australia-must-do-more-on-innovation 2015-12-07T17:00:01+11:00 http://pharmadispatch.com/news/senate-inquiry-recommends-new-innovation-agency 2015-12-04T17:00:01+11:00 http://pharmadispatch.com/news/industry-finds-itself-in-a-familiar-position 2015-12-04T17:31:01+11:00 http://pharmadispatch.com/news/australia-under-prescribing-anticoagulants 2015-12-07T17:00:01+11:00 http://pharmadispatch.com/news/silence-on-biosimilars 2015-12-07T17:00:01+11:00 http://pharmadispatch.com/news/biosimilars-industry-forum-to-meet-department 2015-12-07T17:00:01+11:00 http://pharmadispatch.com/news/expanded-drug-funding-role-for-phi 2015-12-07T17:00:01+11:00 http://pharmadispatch.com/news/labor-announces-new-innovation-measures 2015-12-07T17:00:01+11:00 http://pharmadispatch.com/news/court-backs-government-right-to-compensation 2015-12-08T17:00:01+11:00 http://pharmadispatch.com/news/minister-treasury-and-finance-dont-write-me-a-cheque-for-new-lis 2015-12-08T17:00:01+11:00 http://pharmadispatch.com/news/minister-officially-opens-abbvie-hq 2015-12-08T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-integrates-hospira 2015-12-08T17:00:01+11:00 http://pharmadispatch.com/news/commercialisation-the-first-step-for-mrff 2015-12-08T17:00:01+11:00 http://pharmadispatch.com/news/psa-announces-redevelopment-of-national-headquarters 2015-12-08T17:00:01+11:00 http://pharmadispatch.com/news/a-busy-day-in-bennelong 2015-12-09T17:00:01+11:00 http://pharmadispatch.com/news/novartis-to-open-iconic-headquarters 2015-12-09T17:00:01+11:00 http://pharmadispatch.com/news/pfizer-pleased-with-inflectra-progress 2015-12-09T17:00:01+11:00 http://pharmadispatch.com/news/department-reassures-patients-over-soliris-access 2015-12-09T17:00:01+11:00 http://pharmadispatch.com/news/minister-says-a-lot-in-10-minutes 2015-12-10T17:00:01+11:00 http://pharmadispatch.com/news/minister-support-for-innovation-separate-to-pbs 2015-12-10T17:00:01+11:00 http://pharmadispatch.com/news/another-year-passes-for-co-pay-hike 2015-12-10T17:00:01+11:00 http://pharmadispatch.com/news/what-did-we-learn-yesterday 2015-12-10T17:00:01+11:00 http://pharmadispatch.com/news/job-swap-for-janssens-hourigan 2015-12-11T17:00:01+11:00 http://pharmadispatch.com/news/csl-ships-first-exports-from-new-manufacturing-facility 2015-12-11T17:00:01+11:00 http://pharmadispatch.com/news/msd-congratulates-nobel-prize-winner 2015-12-11T17:00:01+11:00 http://pharmadispatch.com/news/new-fund-will-grow-the-sector 2015-12-11T17:00:01+11:00 http://pharmadispatch.com/news/otc-delistings-dominate-january-pbs-update 2015-12-11T17:00:01+11:00 http://pharmadispatch.com/news/bait-and-switch-on-sustainability 2015-12-11T17:00:01+11:00 http://pharmadispatch.com/news/another-leadership-change-for-industry 2015-12-11T21:39:01+11:00 http://pharmadispatch.com/news/department-publishes-additional-pbac-outcomes 2015-12-14T17:00:01+11:00 http://pharmadispatch.com/news/sector-prepares-for-budget-update 2015-12-14T17:00:01+11:00 http://pharmadispatch.com/news/industry-executive-to-lead-private-health-funds 2015-12-14T17:00:01+11:00 http://pharmadispatch.com/news/az-set-for-another-acquisition 2015-12-14T17:00:01+11:00 http://pharmadispatch.com/news/were-heading-in-the-right-direction-says-hourigan 2015-12-14T17:00:01+11:00 http://pharmadispatch.com/news/another-leader-heads-overseas 2015-12-14T17:00:01+11:00 http://pharmadispatch.com/news/gbma-adds-new-board-members 2015-12-15T17:00:01+11:00 http://pharmadispatch.com/news/pbs-money-goes-elsewhere 2015-12-15T17:00:01+11:00 http://pharmadispatch.com/news/court-backs-accc-on-nurofen 2015-12-15T17:00:01+11:00 http://pharmadispatch.com/news/biosimilars-savings-soar-by-end-of-decade 2015-12-15T17:00:01+11:00 http://pharmadispatch.com/news/still-waiting-for-lsdp-review-report 2015-12-15T17:00:01+11:00 http://pharmadispatch.com/news/guild-cautions-on-co-pay-discounts 2015-12-15T17:00:01+11:00 http://pharmadispatch.com/news/amgen-moves-into-primary-care 2015-12-15T19:00:01+11:00 http://pharmadispatch.com/news/myefo-passes-with-no-mention-of-hep-c 2015-12-16T17:00:01+11:00 http://pharmadispatch.com/news/pbs-down-again 2015-12-15T23:54:01+11:00 http://pharmadispatch.com/news/pbs-cuts-not-even-news-anymore 2015-12-16T17:00:01+11:00 http://pharmadispatch.com/news/rd-tax-claims-soar 2015-12-16T17:00:01+11:00 http://pharmadispatch.com/news/pbs-cut-feeds-into-health-spending 2015-12-16T17:00:01+11:00 http://pharmadispatch.com/news/another-tender-in-health 2015-12-16T17:00:01+11:00 http://pharmadispatch.com/news/more-detail-on-translation-fund 2015-12-16T17:00:01+11:00 http://pharmadispatch.com/news/government-scraps-blood-merger 2015-12-16T17:00:01+11:00 http://pharmadispatch.com/news/sanofi-and-bi-in-20-billion-asset-swap 2015-12-16T17:00:01+11:00 http://pharmadispatch.com/news/gsk-vaccine-manufacturing-boost 2015-12-16T21:29:01+11:00 http://pharmadispatch.com/news/wood-we-understood-the-consequences-of-not-having-an-agreement 2015-12-17T02:35:01+11:00 http://pharmadispatch.com/news/more-positive-new-for-pharmaxis 2015-12-17T17:00:01+11:00 http://pharmadispatch.com/news/ministers-only-looking-at-one-side-of-the-equation 2015-12-17T17:00:01+11:00 http://pharmadispatch.com/news/1-april-price-disclosure-cuts-just-the-beginning 2015-12-17T16:53:01+11:00 http://pharmadispatch.com/news/rd-returns-challenged-by-high-costs 2015-12-18T17:00:01+11:00 http://pharmadispatch.com/news/wood-we-have-a-lot-in-common 2015-12-18T17:00:01+11:00 http://pharmadispatch.com/news/astellas-to-seek-wider-listing-for-xtandi 2015-12-18T17:00:01+11:00 http://pharmadispatch.com/news/new-tga-biosimilar-guideline 2015-12-18T17:00:01+11:00 http://pharmadispatch.com/news/ato-reveals-company-tax-list 2015-12-18T17:00:01+11:00 http://pharmadispatch.com/news/tim-james-departs-ma 2015-12-18T22:29:01+11:00 http://pharmadispatch.com/news/departing-soelberg-cautiously-optimistic 2015-12-22T17:00:01+11:00 http://pharmadispatch.com/news/lilly-says-no-on-insulin-glargine 2015-12-18T23:52:01+11:00 http://pharmadispatch.com/news/pbac-extends-access-to-soliris 2015-12-19T02:22:01+11:00 http://pharmadispatch.com/news/over-1-billion-for-hep-c-medicines 2015-12-20T16:31:01+11:00 http://pharmadispatch.com/news/time-to-start-listening 2015-12-21T17:00:01+11:00 http://pharmadispatch.com/news/maestro-breaks-down-november-pbac-outcomes 2015-12-21T17:00:01+11:00 http://pharmadispatch.com/news/hcv-listings-simply-terrific 2015-12-21T17:00:01+11:00 http://pharmadispatch.com/news/ato-information-dump-corporate-assassination 2015-12-21T17:00:01+11:00 http://pharmadispatch.com/news/cook-time-to-look-ahead 2015-12-21T17:00:01+11:00 http://pharmadispatch.com/news/more-support-hcv-listings 2015-12-22T17:00:01+11:00 http://pharmadispatch.com/news/no-progress-on-national-rare-disease-plan 2015-12-22T17:00:01+11:00 http://pharmadispatch.com/news/ma-begins-the-search 2015-12-22T17:00:01+11:00 http://pharmadispatch.com/news/csl-still-considering-ma-future 2015-12-23T17:00:01+11:00 http://pharmadispatch.com/news/undertainty-over-2016-private-flu-vax-market 2015-12-23T17:00:01+11:00 http://pharmadispatch.com/news/new-leadership-for-sanofi 2015-12-23T17:00:01+11:00 http://pharmadispatch.com/news/uk-industry-restructures-rebates 2015-12-23T17:00:01+11:00